Stimulation	O
of	O
interferon	B-DNA
beta	I-DNA
gene	I-DNA
transcription	O
in	O
vitro	O
by	O
purified	O
NF-kappa	B-protein
B	I-protein
and	O
a	O
novel	O
TH	B-protein
protein	I-protein
.	O

The	O
human	B-DNA
interferon	I-DNA
beta	I-DNA
(	I-DNA
IFN-beta	I-DNA
)	I-DNA
regulatory	I-DNA
element	I-DNA
consists	O
of	O
multiple	O
enhanson	B-DNA
domains	I-DNA
which	O
are	O
targets	O
for	O
transcription	B-protein
factors	I-protein
involved	O
in	O
inducible	O
expression	O
of	O
the	O
promoter	B-DNA
.	O

To	O
further	O
characterize	O
the	O
protein-DNA	O
interactions	O
mediating	O
IFN-beta	B-protein
induction	O
,	O
positive	B-protein
regulatory	I-protein
domain	I-protein
(	I-protein
PRD	I-protein
)	I-protein
II	I-protein
binding	I-protein
proteins	I-protein
were	O
purified	O
from	O
phorbol	O
ester	O
induced	O
Jurkat	B-cell_line
T-cells	I-cell_line
and	O
from	O
IFN	B-cell_line
primed	I-cell_line
,	I-cell_line
cycloheximide/polyinosinic-polycytidylic	I-cell_line
acid	I-cell_line
treated	I-cell_line
HeLa	I-cell_line
S3	I-cell_line
cells	I-cell_line
.	O

From	O
HeLa	B-cell_line
cells	I-cell_line
,	O
two	O
major	O
proteins	O
of	O
52	B-protein
and	I-protein
45	I-protein
kilodaltons	I-protein
(	I-protein
kD	I-protein
)	I-protein
copurified	O
with	O
DNA	O
binding	O
activity	O
,	O
whereas	O
from	O
T-cells	B-cell_type
,	O
four	O
proteins	O
--	O
a	O
major	B-protein
protein	I-protein
of	O
52	B-protein
kD	I-protein
and	O
three	O
minor	B-protein
proteins	I-protein
of	O
82	B-protein
,	O
67	B-protein
,	O
and	O
43-47	B-protein
kD	I-protein
--	O
were	O
purified	O
.	O

Also	O
,	O
an	O
induction	O
specific	B-protein
DNA	I-protein
binding	I-protein
protein	I-protein
was	O
purified	O
from	O
HeLa	B-cell_line
cells	I-cell_line
that	O
interacted	O
with	O
the	O
(	O
AAGTGA	O
)	O
4	O
tetrahexamer	B-DNA
sequence	I-DNA
and	O
the	O
PRDI	B-DNA
domain	I-DNA
.	O

This	O
protein	O
is	O
immunologically	O
distinct	O
from	O
IRF-1/ISGF2	B-protein
.	O

Uninduced	O
or	O
Sendai	O
virus	O
induced	O
HeLa	O
extracts	O
were	O
used	O
to	O
examine	O
transcription	O
in	O
vitro	O
using	O
a	O
series	O
of	O
IFN	B-DNA
beta	I-DNA
promoter	I-DNA
deletions	I-DNA
.	O

Deletions	O
upstream	O
of	O
the	O
PRDII	B-DNA
element	I-DNA
increased	O
transcription	O
in	O
the	O
uninduced	O
extract	O
,	O
indicating	O
predominantly	O
negative	O
regulation	O
of	O
the	O
promoter	B-DNA
.	O

A	O
2-4-fold	O
increase	O
in	O
IFN-beta	B-DNA
promoter	I-DNA
transcription	O
was	O
observed	O
in	O
Sendai	O
virus	O
induced	O
extracts	O
,	O
and	O
deletion	O
of	O
PRDI	B-DNA
and	O
PRDII	B-DNA
elements	I-DNA
decreased	O
this	O
induced	O
level	O
of	O
transcription	O
.	O

When	O
purified	O
PRDII	B-protein
and	I-protein
tetrahexamer	I-protein
binding	I-protein
proteins	I-protein
were	O
added	O
to	O
the	O
induced	O
extract	O
,	O
a	O
4-fold	O
increase	O
in	O
transcription	O
was	O
observed	O
.	O

These	O
experiments	O
demonstrate	O
that	O
it	O
is	O
possible	O
to	O
modulate	O
IFN-beta	O
transcription	O
in	O
vitro	O
but	O
indicate	O
that	O
additional	O
proteins	O
may	O
be	O
required	O
to	O
fully	O
activate	O
IFN-beta	B-protein
transcription	O
.	O

Vol	NULL
.	NULL

2	NULL
,	NULL
323-333	NULL
,	NULL
July	NULL
1991	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
323	NULL
Stimulation	NULL
of	NULL
Interferon	NULL
&	NULL
Gene	NULL
Transcriqtion	NULL
in	NULL
Vitro	NULL
by	NULL
Purified	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
a	NULL
Novel	NULL
TH	NULL
Protein	NULL
Lucie	NULL
Cohen	NULL
,	NULL
Judith	NULL
Lacoste	NULL
,	NULL
Michael	NULL
Parniak	NULL
,	NULL
Luc	NULL
Daigneault	NULL
,	NULL
Daniel	NULL
Skup	NULL
,	NULL
and	NULL
John	NULL
Hiscott	NULL
Lady	NULL
Davis	NULL
Institute	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
Sir	NULL
Mortimer	NULL
B.	NULL
Davis-Jewish	NULL
General	NULL
Hospital	NULL
[	NULL
L.	NULL
C.	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
J.	NULL
H.	NULL
]	NULL
;	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
McGill	NULL
University	NULL
[	NULL
L.	NULL
C.	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
J.	NULL
H.	NULL
]	NULL
;	NULL
and	NULL
Institut	NULL
du	NULL
Cancer	NULL
de	NULL
Montreal	NULL
[	NULL
L.	NULL
D.	NULL
,	NULL
D.	NULL
S.	NULL
]	NULL
,	NULL
Montreal	NULL
,	NULL
Canada	NULL
Abstract	NULL
The	NULL
human	NULL
interferon	NULL
$	NULL
(	NULL
IFN-8	NULL
)	NULL
regulatory	NULL
element	NULL
consists	NULL
of	NULL
multiple	NULL
enhanson	NULL
domains	NULL
which	NULL
are	NULL
targets	NULL
for	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
protein-DNA	NULL
interactions	NULL
mediating	NULL
IFN-8	NULL
induction	NULL
,	NULL
positive	NULL
regulatory	NULL
domain	NULL
(	NULL
PRD	NULL
)	NULL
II	NULL
binding	NULL
proteins	NULL
were	NULL
purified	NULL
from	NULL
phorbol	NULL
ester	NULL
induced	NULL
Jurkat	NULL
T-cells	NULL
and	NULL
from	NULL
IFN	NULL
primed	NULL
,	NULL
cycloheximide/polyinosinic-polycytidylic	NULL
acid	NULL
treated	NULL
Hela	NULL
$	NULL
3	NULL
cells	NULL
.	NULL

From	NULL
Hela	NULL
cells	NULL
,	NULL
two	NULL
major	NULL
proteins	NULL
of	NULL
52	NULL
and	NULL
45	NULL
kilodaltons	NULL
(	NULL
kD	NULL
)	NULL
copurified	NULL
with	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
whereas	NULL
from	NULL
T-cells	NULL
,	NULL
four	NULL
proteins-a	NULL
major	NULL
protein	NULL
of	NULL
52	NULL
kD	NULL
and	NULL
three	NULL
minor	NULL
proteins	NULL
of	NULL
82	NULL
,	NULL
67	NULL
,	NULL
and	NULL
43-47	NULL
kD-were	NULL
purified	NULL
.	NULL

Also	NULL
,	NULL
an	NULL
induction	NULL
specific	NULL
DNA	NULL
binding	NULL
protein	NULL
was	NULL
purified	NULL
from	NULL
Hela	NULL
cells	NULL
that	NULL
interacted	NULL
with	NULL
the	NULL
(	NULL
AAGTGA	NULL
)	NULL
,	NULL
tetrahexamer	NULL
sequence	NULL
and	NULL
the	NULL
PRDI	NULL
domain	NULL
.	NULL

This	NULL
protein	NULL
is	NULL
immunologically	NULL
distinct	NULL
from	NULL
IRF-1/ISGF2	NULL
.	NULL

Uninduced	NULL
or	NULL
Sendai	NULL
virus	NULL
induced	NULL
Hela	NULL
extracts	NULL
were	NULL
used	NULL
to	NULL
examine	NULL
transcription	NULL
in	NULL
vitro	NULL
using	NULL
a	NULL
series	NULL
of	NULL
IFN	NULL
$	NULL
promoter	NULL
deletions	NULL
.	NULL

Deletions	NULL
upstream	NULL
of	NULL
the	NULL
PRDIl	NULL
element	NULL
increased	NULL
transcription	NULL
in	NULL
the	NULL
uninduced	NULL
extract	NULL
,	NULL
indicating	NULL
predominantly	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

A	NULL
2-4-fold	NULL
increase	NULL
in	NULL
IFN-8	NULL
promoter	NULL
transcription	NULL
was	NULL
observed	NULL
in	NULL
Sendai	NULL
virus	NULL
induced	NULL
extracts	NULL
,	NULL
and	NULL
deletion	NULL
of	NULL
PRDI	NULL
and	NULL
PRDII	NULL
elements	NULL
decreased	NULL
this	NULL
induced	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

When	NULL
purified	NULL
PRDII	NULL
and	NULL
tetrahexamer	NULL
binding	NULL
proteins	NULL
were	NULL
added	NULL
to	NULL
the	NULL
induced	NULL
extract	NULL
,	NULL
a	NULL
4-fold	NULL
increase	NULL
in	NULL
transcription	NULL
was	NULL
observed	NULL
.	NULL

These	NULL
experiments	NULL
demonstrate	NULL
that	NULL
it	NULL
is	NULL
possible	NULL
to	NULL
modulate	NULL
IFN-8	NULL
transcription	NULL
in	NULL
vitro	NULL
but	NULL
indicate	NULL
that	NULL
additional	NULL
proteins	NULL
may	NULL
be	NULL
required	NULL
to	NULL
fully	NULL
activate	NULL
IFN-8	NULL
transcription	NULL
.	NULL

Received	NULL
3/4/91	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
research	NULL
grants	NULL
to	NULL
J.	NULL
H.	NULL
from	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
,	NULL
the	NULL
Cancer	NULL
Research	NULL
Society	NULL
,	NULL
and	NULL
Health	NULL
and	NULL
Welfare	NULL
Canada	NULL
.	NULL

J.	NULL
H.	NULL
is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
senior	NULL
chercheur-boursier	NULL
from	NULL
the	NULL
Fonds	NULL
de	NULL
la	NULL
Recherche	NULL
en	NULL
Santé	NULL
du	NULL
Québec	NULL
.	NULL

L.	NULL
C.	NULL
is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
studentship	NULL
from	NULL
Cancer	NULL
Research	NULL
Society	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
studentship	NULL
from	NULL
FCAR	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Lady	NULL
Davis	NULL
Institute	NULL
of	NULL
Medical	NULL
Research	NULL
,	NULL
Sir	NULL
Mortimer	NULL
B.	NULL
Davis-Jewish	NULL
General	NULL
Hospital	NULL
,	NULL
3755	NULL
Cote	NULL
Ste	NULL
.	NULL

Catherine	NULL
Road	NULL
,	NULL
Montreal	NULL
,	NULL
Quebec	NULL
H3T	NULL
1E2	NULL
,	NULL
Canada	NULL
.	NULL

Introduction	NULL
Induction	NULL
of	NULL
type	NULL
1	NULL
IFN®	NULL
genes	NULL
(	NULL
IFN-a	NULL
and	NULL
IFN-8	NULL
)	NULL
occurs	NULL
as	NULL
an	NULL
early	NULL
response	NULL
to	NULL
virus	NULL
infection	NULL
in	NULL
hemopoietic	NULL
,	NULL
epithelial	NULL
,	NULL
and	NULL
fibroblastic	NULL
cells	NULL
.	NULL

Activation	NULL
and	NULL
repression	NULL
of	NULL
interferon	NULL
8	NULL
expression	NULL
is	NULL
controlled	NULL
primarily	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
and	NULL
is	NULL
mediated	NULL
by	NULL
multiple	NULL
factors	NULL
interacting	NULL
with	NULL
overlapping	NULL
regulatory	NULL
promoter	NULL
domains	NULL
,	NULL
located	NULL
immediately	NULL
adjacent	NULL
to	NULL
the	NULL
structural	NULL
gene	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Three	NULL
positive	NULL
regulatory	NULL
domains	NULL
and	NULL
two	NULL
negative	NULL
regulatory	NULL
domains	NULL
have	NULL
been	NULL
defined	NULL
by	NULL
mutational	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

The	NULL
PRDt	NULL
domain	NULL
(	NULL
-77	NULL
to	NULL
-64	NULL
)	NULL
functions	NULL
as	NULL
a	NULL
constitutive	NULL
or	NULL
virus-inducible	NULL
enhancer	NULL
when	NULL
multimer-ized	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Tandem	NULL
repeats	NULL
of	NULL
the	NULL
hexamer	NULL
sequence	NULL
AAGTGA	NULL
,	NULL
a	NULL
conserved	NULL
sequence	NULL
motif	NULL
present	NULL
twice	NULL
in	NULL
PRDI	NULL
,	NULL
is	NULL
also	NULL
a	NULL
virus	NULL
inducible	NULL
element	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
positive	NULL
regulatory	NULL
domain	NULL
PRDII	NULL
(	NULL
-66	NULL
to	NULL
-55	NULL
)	NULL
is	NULL
also	NULL
essential	NULL
for	NULL
virus	NULL
inducibility	NULL
;	NULL
base	NULL
mutations	NULL
or	NULL
deletions	NULL
which	NULL
alter	NULL
the	NULL
PRDIIl	NULL
domain	NULL
of	NULL
the	NULL
natural	NULL
promoter	NULL
cause	NULL
a	NULL
loss	NULL
in	NULL
virus	NULL
inducibility	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Multiple	NULL
copies	NULL
of	NULL
this	NULL
element	NULL
likewise	NULL
function	NULL
as	NULL
a	NULL
virus-inducible	NULL
enhancer	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
third	NULL
positive	NULL
regulatory	NULL
domain	NULL
,	NULL
PRDIII	NULL
(	NULL
-94	NULL
to	NULL
-78	NULL
)	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
synergize	NULL
with	NULL
PRDI	NULL
and	NULL
PRDil	NULL
domains	NULL
to	NULL
increase	NULL
virus	NULL
inducibility	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Two	NULL
negative	NULL
regulatory	NULL
domains	NULL
,	NULL
NRDI	NULL
and	NULL
NRDHI	NULL
,	NULL
were	NULL
identified	NULL
by	NULL
mutational	NULL
analysis	NULL
and	NULL
in	NULL
vivo	NULL
footprinting	NULL
(	NULL
6	NULL
,	NULL
8	NULL
)	NULL
,	NULL
but	NULL
the	NULL
exact	NULL
boundaries	NULL
of	NULL
these	NULL
regions	NULL
have	NULL
not	NULL
been	NULL
determined	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
for	NULL
the	NULL
relative	NULL
location	NULL
of	NULL
these	NULL
regions	NULL
)	NULL
.	NULL

The	NULL
complexity	NULL
of	NULL
the	NULL
induction	NULL
process	NULL
suggested	NULL
by	NULL
the	NULL
organization	NULL
of	NULL
the	NULL
IFN-8	NULL
promoter	NULL
is	NULL
further	NULL
emphasized	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
multiple	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
PRD	NULL
and	NULL
PRDIL	NULL
domains	NULL
.	NULL

Three	NULL
proteins	NULL
have	NULL
been	NULL
characterized	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
PRDi	NULL
domain	NULL
.	NULL

IRF-1	NULL
is	NULL
involved	NULL
in	NULL
positive	NULL
virus	NULL
mediated	NULL
induction	NULL
of	NULL
IFN-8	NULL
and	NULL
IFN-a	NULL
gene	NULL
expression	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
ISGF-2	NULL
,	NULL
a	NULL
protein	NULL
recognizing	NULL
the	NULL
promoters	NULL
of	NULL
IFN-stimulated	NULL
genes	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
IRF-1	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Two	NULL
other	NULL
PRDI	NULL
binding	NULL
proteins	NULL
,	NULL
IRF-2-a	NULL
protein	NULL
structurally	NULL
related	NULL
to	NULL
IRF-1-and	NULL
PRDI-BF1-an	NULL
88	NULL
kD	NULL
zinc	NULL
finger	NULL
containing	NULL
protein-have	NULL
been	NULL
identified	NULL
as	NULL
transcriptional	NULL
repressors	NULL
of	NULL
IFN-8	NULL
expression	NULL
in	NULL
cotransfection	NULL
experiments	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

The	NULL
PRDII	NULL
domain	NULL
interacts	NULL
with	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
and	NULL
with	NULL
a	NULL
300	NULL
kD	NULL
protein	NULL
termed	NULL
PRDII-BF	NULL
1	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
virus	NULL
or	NULL
double	NULL
stranded	NULL
RNA	NULL
correlates	NULL
directly	NULL
with	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IFN	NULL
,	NULL
interferon	NULL
;	NULL
PRD	NULL
,	NULL
positive	NULL
regulatory	NULL
domain	NULL
;	NULL
NRD	NULL
,	NULL
negative	NULL
regulatory	NULL
domain	NULL
;	NULL
IRF	NULL
,	NULL
interferon	NULL
regulatory	NULL
factor	NULL
;	NULL
ISGF	NULL
,	NULL
interferon	NULL
stimulated	NULL
gene	NULL
factor	NULL
;	NULL
kD	NULL
,	NULL
kilodalton	NULL
(	NULL
s	NULL
)	NULL
;	NULL
poly	NULL
[	NULL
1	NULL
:	NULL
C	NULL
]	NULL
,	NULL
polyinosinic-polycytidylic	NULL
acid	NULL
(	NULL
other	NULL
forms	NULL
are	NULL
similarly	NULL
desig-nated	NULL
)	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
;	NULL
TH	NULL
,	NULL
tetrahexamer	NULL
;	NULL
HIV	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
;	NULL
WCE	NULL
,	NULL
whole	NULL
cell	NULL
extract	NULL
;	NULL
SDS	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
;	NULL
IRE	NULL
,	NULL
interferon	NULL
regulatory	NULL
element	NULL
;	NULL
BrdUrd	NULL
,	NULL
5-bromodeoxyuri-dine	NULL
;	NULL
RSG	NULL
,	NULL
rabbit	NULL
8-globin	NULL
gene	NULL
;	NULL
Hepes	NULL
,	NULL
4-	NULL
(	NULL
2-hydroxyethyl	NULL
)	NULL
-1-piperazine-ethanesulfonic	NULL
acid	NULL
;	NULL
PMSF	NULL
,	NULL
phenyimethylsulfonyl	NULL
fluoride	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
}	NULL
.	NULL

324	NULL
IFN-8	NULL
Protein-DNA	NULL
Interactions	NULL
NRDII	NULL
PRD	NULL
111	NULL
PRD	NULL
I	NULL
PRD	NULL
II	NULL
NRD	NULL
!	NULL

...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
Eng-	NULL
]	NULL
Epps	NULL
90Ammrmmwmwtmwreacnw	NULL
‘	NULL
rmmmcCTCTWYWCCATCTCATATMA	NULL
?	NULL

AoeccATwWAOOGWATTCTAACT	NULL
--	NULL
-	NULL
~~	NULL
Factors	NULL
IRF-1-like	NULL
__	NULL
IRF-12ISGF-2	NULL
NF-	NULL
«	NULL
B	NULL
+111	NULL
p907	NULL
67	NULL
pBiz	NULL
p1009	NULL
56	NULL
p901	NULL
«	NULL
34	NULL
___	NULL
p1007	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Organization	NULL
of	NULL
the	NULL
interferon	NULL
8	NULL
promoter	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
promoter	NULL
from	NULL
nucleotides	NULL
-140	NULL
to	NULL
+10	NULL
is	NULL
shown	NULL
.	NULL

Boxed	NULL
areas	NULL
outline	NULL
the	NULL
two	NULL
positive	NULL
regulatory	NULL
domains	NULL
of	NULL
the	NULL
IRE	NULL
(	NULL
PRD	NULL
!	NULL

and	NULL
PRD	NULL
!	NULL

1	NULL
)	NULL
(	NULL
3	NULL
)	NULL
and	NULL
a	NULL
third	NULL
positive	NULL
regulatory	NULL
domain	NULL
adjacent	NULL
to	NULL
the	NULL
IRE	NULL
(	NULL
PRDIII	NULL
)	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Location	NULL
of	NULL
the	NULL
two	NULL
negative	NULL
regulatory	NULL
domains	NULL
(	NULL
NRDI	NULL
and	NULL
NRD	NULL
!	NULL
)	NULL

is	NULL
shown	NULL
above	NULL
the	NULL
sequence	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
.	NULL

GAAANN	NULL
motifs	NULL
(	NULL
38	NULL
)	NULL
present	NULL
throughout	NULL
the	NULL
promoter	NULL
are	NULL
underlined	NULL
.	NULL

Open	NULL
circle	NULL
,	NULL
the	NULL
TATA	NULL
box	NULL
;	NULL
arrow	NULL
,	NULL
the	NULL
mRNA	NULL
start	NULL
site	NULL
.	NULL

Transcription	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
PRDH	NULL
and	NULL
PRD	NULL
!	NULL

domains	NULL
of	NULL
the	NULL
promoter	NULL
are	NULL
listed	NULL
below	NULL
the	NULL
sequence	NULL
.	NULL

The	NULL
5°	NULL
end	NULL
points	NULL
of	NULL
the	NULL
deletion	NULL
series	NULL
and	NULL
the	NULL
plasmid	NULL
names	NULL
are	NULL
shown	NULL
below	NULL
the	NULL
diagram	NULL
.	NULL

induction	NULL
of	NULL
IFN-8	NULL
transcription	NULL
and	NULL
is	NULL
thus	NULL
the	NULL
only	NULL
PRDIl	NULL
binding	NULL
protein	NULL
implicated	NULL
in	NULL
positive	NULL
regulation	NULL
of	NULL
the	NULL
IFN-8	NULL
promoter	NULL
(	NULL
18-22	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
multi-subunit	NULL
transcription	NULL
regulatory	NULL
com-plex	NULL
,	NULL
inducible	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
agents	NULL
including	NULL
cytokines	NULL
,	NULL
mitogens	NULL
,	NULL
phorbol	NULL
esters	NULL
,	NULL
and	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
protein	NULL
(	NULL
16	NULL
,	NULL
20	NULL
,	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
induction	NULL
is	NULL
a	NULL
posttranslational	NULL
event	NULL
.	NULL

Latent	NULL
NF-	NULL
«	NULL
B	NULL
exists	NULL
in	NULL
the	NULL
cytoplasm	NULL
as	NULL
a	NULL
hetero-trimeric	NULL
protein	NULL
;	NULL
induction	NULL
involves	NULL
the	NULL
dissociation	NULL
of	NULL
a	NULL
p65-p50	NULL
heterodimer	NULL
from	NULL
a	NULL
regulatory	NULL
protein	NULL
(	NULL
inhibitor	NULL
of	NULL
«	NULL
B	NULL
or	NULL
IB	NULL
)	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
25-27	NULL
)	NULL
.	NULL

Both	NULL
p50	NULL
and	NULL
p65	NULL
possess	NULL
intrinsic	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
and	NULL
p65	NULL
is	NULL
indispensible	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
the	NULL
IxB	NULL
regulatory	NULL
polypeptide	NULL
(	NULL
26-28	NULL
)	NULL
.	NULL

The	NULL
complexity	NULL
of	NULL
the	NULL
interactions	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
multiple	NULL
enhancer	NULL
elements	NULL
has	NULL
been	NULL
increased	NULL
recently	NULL
with	NULL
the	NULL
identification	NULL
of	NULL
at	NULL
least	NULL
four	NULL
different	NULL
inducible	NULL
DNA-binding	NULL
proteins-p50	NULL
,	NULL
p55	NULL
,	NULL
p75	NULL
,	NULL
and	NULL
p85-all	NULL
of	NULL
which	NULL
exist	NULL
as	NULL
latent	NULL
cytoplasmic	NULL
precursors	NULL
that	NULL
can	NULL
be	NULL
activated	NULL
to	NULL
nuclear	NULL
forms	NULL
with	NULL
biphasic	NULL
kinetics	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
cloning	NULL
of	NULL
the	NULL
precursor	NULL
complementary	NULL
DNA	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
demonstrated	NULL
that	NULL
p50	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
KBF-1	NULL
protein	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
1	NULL
H2K	NULL
gene	NULL
and	NULL
,	NULL
more	NULL
importantly	NULL
,	NULL
that	NULL
KBF-1/NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
rel	NULL
family	NULL
of	NULL
oncoproteins	NULL
(	NULL
30-34	NULL
)	NULL
.	NULL

The	NULL
p85	NULL
protein	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
correspond	NULL
to	NULL
c-rel	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Like	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
the	NULL
rel	NULL
family	NULL
of	NULL
proteins	NULL
displays	NULL
nuclear-cytoplasmic	NULL
patterns	NULL
of	NULL
subcellular	NULL
localization	NULL
,	NULL
possibly	NULL
regulated	NULL
via	NULL
I	NULL
«	NULL
B-like	NULL
proteins	NULL
(	NULL
34	NULL
)	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
role	NULL
of	NULL
different	NULL
proteins	NULL
mediating	NULL
IFN-8	NULL
induction	NULL
,	NULL
PRD	NULL
!	NULL

and	NULL
PRDII	NULL
binding	NULL
proteins	NULL
were	NULL
purified	NULL
from	NULL
IFN	NULL
primed	NULL
,	NULL
cycloheximide/	NULL
poly	NULL
[	NULL
1	NULL
:	NULL
C	NULL
]	NULL
treated	NULL
Hela	NULL
S3	NULL
cells	NULL
and	NULL
from	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
lymphoid	NULL
cells	NULL
.	NULL

These	NULL
proteins	NULL
were	NULL
added	NULL
to	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
consisting	NULL
of	NULL
a	NULL
basal	NULL
Hela	NULL
cell	NULL
nuclear	NULL
extract	NULL
to	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
different	NULL
proteins	NULL
on	NULL
IFN-8	NULL
gene	NULL
transcription	NULL
.	NULL

Both	NULL
PRDI	NULL
and	NULL
PRDII	NULL
binding	NULL
proteins	NULL
were	NULL
capable	NULL
of	NULL
stimulating	NULL
accurately	NULL
initiated	NULL
IFN-8	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

Results	NULL
PRDII	NULL
Binding	NULL
Activity	NULL
in	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
Cells	NULL
.	NULL

The	NULL
organization	NULL
of	NULL
the	NULL
IFN-8	NULL
promoter	NULL
and	NULL
the	NULL
5	NULL
end	NULL
points	NULL
of	NULL
deletions	NULL
are	NULL
illustrated	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Inducibility	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
two	NULL
different	NULL
cell	NULL
types	NULL
:	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
following	NULL
induction	NULL
with	NULL
phorbol	NULL
ester	NULL
(	NULL
PMA	NULL
)	NULL
or	NULL
in	NULL
HeLa	NULL
S3	NULL
cells	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
IFN	NULL
,	NULL
cycloheximide	NULL
,	NULL
and	NULL
poly	NULL
[	NULL
I	NULL
:	NULL
C	NULL
]	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
demonstrates	NULL
that	NULL
extracts	NULL
from	NULL
uninduced	NULL
Jurkat	NULL
T-cells	NULL
contain	NULL
little	NULL
DNA	NULL
binding	NULL
activity	NULL
capable	NULL
of	NULL
recognizing	NULL
the	NULL
PRDII	NULL
domain	NULL
(	NULL
P2	NULL
probe	NULL
)	NULL
or	NULL
the	NULL
HIV	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
Lanes	NULL
1-3	NULL
and	NULL
7-9	NULL
)	NULL
,	NULL
whereas	NULL
following	NULL
phorbol	NULL
ester	NULL
treatment	NULL
,	NULL
a	NULL
40-fold	NULL
increase	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Lanes	NULL
4-6	NULL
and	NULL
10-12	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
demonstrated	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
PRD	NULL
protein-DNA	NULL
complexes	NULL
found	NULL
in	NULL
PMA-induced	NULL
Jurkat	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
;	NULL
both	NULL
P2	NULL
and	NULL
the	NULL
HIV	NULL
enhancer	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
entire	NULL
IRE	NULL
sequence	NULL
containing	NULL
a	NULL
single	NULL
PRDII	NULL
site	NULL
,	NULL
competed	NULL
for	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
Lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
a	NULL
mutated	NULL
HIV	NULL
enhancer	NULL
or	NULL
heterologous	NULL
sequences	NULL
(	NULL
P1	NULL
and	NULL
P6	NULL
)	NULL
from	NULL
the	NULL
IFN-8	NULL
promoter	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
PRDII	NULL
specific	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
Lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
)	NULL
.	NULL

HeLa	NULL
S3	NULL
cells	NULL
also	NULL
contained	NULL
DNA	NULL
binding	NULL
activity	NULL
with	NULL
similar	NULL
specific-ity	NULL
:	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
,	NULL
significant	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
uninduced	NULL
cell	NULL
extracts	NULL
and	NULL
was	NULL
about	NULL
5-fold	NULL
inducible	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
IFN/cycloheximide/	NULL
poly	NULL
[	NULL
I	NULL
:	NULL
C	NULL
]	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

In	NULL
transfection	NULL
experiments	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
DNA	NULL
binding	NULL
inducibility	NULL
observed	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
correlated	NULL
with	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
PRDII	NULL
containing	NULL
plasmids	NULL
(	NULL
7	NULL
)	NULL
;	NULL
a	NULL
plasmid	NULL
with	NULL
one	NULL
copy	NULL
of	NULL
P2	NULL
was	NULL
40-fold	NULL
inducible	NULL
by	NULL
PMA	NULL
treatment	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
whereas	NULL
in	NULL
Hela	NULL
S3	NULL
cells	NULL
,	NULL
the	NULL
same	NULL
plasmid	NULL
was	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
325	NULL
A	NULL
P2	NULL
Probe	NULL
Uninduced	NULL
_	NULL
PMA-Induced	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Inducibility	NULL
of	NULL
PRDI	NULL
binding	NULL
activity	NULL
in	NULL
Jurkat	NULL
and	NULL
Hela	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
titration	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
Lane	NULL
No	NULL
.	NULL

1	NULL
-	NULL
30	NULL
30	NULL
40	NULL
5	NULL
06	NULL
7	NULL
,	NULL
8	NULL
,	NULL
9	NULL
)	NULL
or	NULL
8-h	NULL
PMA	NULL
induced	NULL
(	NULL
Lanes	NULL
xB	NULL
-t-4	NULL
,	NULL
5	NULL
,	NULL
6	NULL
and	NULL
10	NULL
,	NULL
11	NULL
,	NULL
12	NULL
)	NULL
WCE	NULL
from	NULL
complex	NULL
Jurkat	NULL
T-cells	NULL
,	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
P2	NULL
(	NULL
P2	NULL
probe	NULL
,	NULL
5	NULL
``	NULL
-GGG	NULL
AAATTCCGGGAAATTCC-3*	NULL
;	NULL
Lanes	NULL
1-6	NULL
)	NULL
or	NULL
HIV	NULL
oligonucleotide	NULL
{	NULL
HIV	NULL
,	NULL
5	NULL
``	NULL
-AGGGACTTTCCGCTGG	NULL
GGACTTTCC-3	NULL
'	NULL
;	NULL
Lanes	NULL
7-12	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
ug	NULL
of	NULL
poly	NULL
{	NULL
dH	NULL
:	NULL
dC	NULL
]	NULL
.	NULL

P	NULL
,	NULL
free	NULL
probe	NULL
;	NULL
xB	NULL
,	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

B	NULL
,	NULL
competition	NULL
analysis	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Twelve	NULL
ug	NULL
of	NULL
PMA	NULL
induced	NULL
extract	NULL
were	NULL
incubated	NULL
as	NULL
above	NULL
with	NULL
the	NULL
P2	NULL
probe	NULL
and	NULL
with	NULL
no	NULL
competitor	NULL
(	NULL
Lane	NULL
1	NULL
)	NULL
or	NULL
20	NULL
ng	NULL
of	NULL
different	NULL
competitor	NULL
oligonucleotides	NULL
as	NULL
listed	NULL
below	NULL
the	NULL
figure	NULL
(	NULL
Lanes	NULL
2-7	NULL
)	NULL
.	NULL

Cc	NULL
HIVm	NULL
,	NULL
an	NULL
oligonucleotide	NULL
contain	NULL
ing	NULL
a	NULL
clustered	NULL
mutation	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
(	NULL
20	NULL
)	NULL
;	NULL
P1	NULL
,	NULL
an	NULL
oligo-	NULL
ug	NULL
of	NULL
uninduced	NULL
(	NULL
Lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
and	NULL
u.	NULL
nucleotide	NULL
representing	NULL
the	NULL
se-	NULL
Lane	NULL
No	NULL
.	NULL

quence	NULL
~79	NULL
to	NULL
-64	NULL
of	NULL
the	NULL
IFN-8	NULL
promoter	NULL
;	NULL
JRE	NULL
,	NULL
an	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
sequence	NULL
-79	NULL
to	NULL
-36	NULL
of	NULL
the	NULL
IFN-8	NULL
promoter	NULL
;	NULL
P6	NULL
,	NULL
an	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
xB	NULL
-	NULL
»	NULL
sequence	NULL
-133	NULL
to	NULL
-92	NULL
of	NULL
the	NULL
IFN-	NULL
complex	NULL
B	NULL
promoter	NULL
(	NULL
35	NULL
)	NULL
.	NULL

C	NULL
,	NULL
titration	NULL
and	NULL
competition	NULL
-	NULL
analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
HeLa	NULL
S3	NULL
cells	NULL
.	NULL

Five	NULL
,	NULL
10	NULL
,	NULL
and	NULL
15	NULL
ug	NULL
of	NULL
uninduced	NULL
(	NULL
Lanes	NULL
1-3	NULL
)	NULL
or	NULL
IFN/cycloheximide/	NULL
poly	NULL
[	NULL
}	NULL
:	NULL
C	NULL
]	NULL
-	NULL
induced	NULL
{	NULL
Lanes	NULL
4-6	NULL
)	NULL
WCE	NULL
from	NULL
HeLa	NULL
$	NULL
3	NULL
cells	NULL
were	NULL
in	NULL
cubated	NULL
with	NULL
the	NULL
HIV	NULL
probe	NULL
.	NULL

Lane	NULL
7	NULL
contains	NULL
15	NULL
ag	NULL
of	NULL
induced	NULL
ex	NULL
tract	NULL
;	NULL
in	NULL
Lanes	NULL
8-12	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
com	NULL
petitor	NULL
__	NULL
oligonucleotide	NULL
_	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
,	NULL
as	NULL
listed	NULL
below	NULL
the	NULL
lane	NULL
.	NULL

induced	NULL
5-fold	NULL
by	NULL
cycloheximide/poly	NULL
[	NULL
I	NULL
:	NULL
C	NULL
]	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
demonstrated	NULL
a	NULL
direct	NULL
correlation	NULL
between	NULL
PRDII	NULL
DNA	NULL
binding	NULL
activity	NULL
and	NULL
transcriptional	NULL
activation	NULL
.	NULL

Purification	NULL
of	NULL
Cellular	NULL
Proteins	NULL
Interacting	NULL
with	NULL
the	NULL
PRDII	NULL
Domain	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
biochemical	NULL
differences	NULL
existed	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
protein-DNA	NULL
complexes	NULL
induced	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
PRDIIL	NULL
DNA	NULL
binding	NULL
activities	NULL
were	NULL
purified	NULL
from	NULL
PMA	NULL
treated	NULL
Jurkat	NULL
T-cells	NULL
and	NULL
IFN/cycloheximide/poly	NULL
[	NULL
1	NULL
:	NULL
C	NULL
]	NULL
treated	NULL
Hela	NULL
S3	NULL
cells	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
induced	NULL
cells	NULL
,	NULL
fractionated	NULL
by	NULL
gel	NULL
filtration	NULL
on	NULL
Sephacryl	NULL
S-300	NULL
columns	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
three	NULL
cycles	NULL
of	NULL
specific	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
.	NULL

The	NULL
profile	NULL
of	NULL
Jurkat	NULL
cell	NULL
PRDIlL	NULL
DNA	NULL
binding	NULL
activity	NULL
eluting	NULL
from	NULL
the	NULL
Sephacryl	NULL
S	NULL
$	NULL
-300	NULL
column	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
;	NULL
two	NULL
peaks	NULL
of	NULL
activity	NULL
were	NULL
detected-the	NULL
first	NULL
eluting	NULL
with	NULL
the	NULL
majority	NULL
of	NULL
total	NULL
cellular	NULL
protein	NULL
in	NULL
fractions	NULL
11-20	NULL
,	NULL
and	NULL
the	NULL
second	NULL
eluting	NULL
in	NULL
fractions	NULL
28-35	NULL
.	NULL

Multiple	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
observed	NULL
HIV	NULL
Probe	NULL
B	NULL
Uninduced	NULL
_	NULL
PMA-Induced	NULL
P2	NULL
Probe	NULL
7	NULL
%	NULL
9	NULL
10	NULL
1	NULL
a2	NULL
Lane	NULL
No	NULL
,	NULL
-	NULL
100	NULL
200300	NULL
40050	NULL
6	NULL
07	NULL
KB	NULL
-	NULL
#	NULL
»	NULL
complex	NULL
P	NULL
--	NULL
Competitor	NULL
DNA	NULL
P2	NULL
HV	NULL
HiVin	NULL
PI	NULL
IRE	NULL
P6	NULL
P2	NULL
Probe	NULL
Uninduced	NULL
Induced	NULL
P2	NULL
Probe	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
70	NULL
8	NULL
%	NULL
9	NULL
10	NULL
11	NULL
12	NULL
will	NULL
!	NULL

“	NULL
d	NULL
W	NULL
t	NULL
Competitor	NULL
DNA	NULL
-	NULL
P2	NULL
HIVHIVm	NULL
IRE	NULL
P6	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
these	NULL
fractions	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
S-300	NULL
active	NULL
pool	NULL
from	NULL
Jurkat	NULL
cells	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
heparin-Sepharose	NULL
column	NULL
to	NULL
partially	NULL
fractionate	NULL
a	NULL
nonspecific	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
proteins	NULL
eluting	NULL
from	NULL
the	NULL
column	NULL
at	NULL
0.6	NULL
m	NULL
KCl	NULL
were	NULL
subjected	NULL
to	NULL
three	NULL
cycles	NULL
of	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
.	NULL

PRDIL	NULL
DNA	NULL
binding	NULL
activity	NULL
eluting	NULL
from	NULL
the	NULL
DNA	NULL
affinity	NULL
column	NULL
at	NULL
0.4-0.5	NULL
m	NULL
KCl	NULL
was	NULL
highly	NULL
enriched	NULL
after	NULL
two	NULL
cycles	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
this	NULL
activity	NULL
was	NULL
purified	NULL
~20,000-fold	NULL
after	NULL
the	NULL
third	NULL
cycle	NULL
of	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
PRDIlL	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
purified	NULL
from	NULL
HeLa	NULL
cell	NULL
extracts	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
;	NULL
interestingly	NULL
,	NULL
throughout	NULL
the	NULL
purification	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
resolved	NULL
as	NULL
a	NULL
single	NULL
protein-DNA	NULL
complex	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

The	NULL
polypeptides	NULL
present	NULL
in	NULL
different	NULL
fractions	NULL
were	NULL
analyzed	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
purified	NULL
fraction	NULL
from	NULL
HeLa	NULL
cells	NULL
contained	NULL
two	NULL
proteins	NULL
of	NULL
52	NULL
and	NULL
45	NULL
kD	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
Lane	NULL
2	NULL
)	NULL
,	NULL
probably	NULL
corresponding	NULL
326	NULL
IFN-3	NULL
Protein-UDNA	NULL
Interactions	NULL
2	NULL
m	NULL
L5	NULL
r—-—-——S-300	NULL
Fractions————	NULL
‘	NULL
,	NULL
0	NULL
A	NULL
<	NULL
Ii0	NULL
11121314	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
2223	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
29	NULL
30	NULL
31	NULL
3233	NULL
34	NULL
3536	NULL
2	NULL
``	NULL
TT	NULL
1	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
6	NULL
€	NULL
._	NULL
2.5	NULL
G	NULL
3	NULL
8	NULL
3	NULL
e	NULL
4	NULL
20	NULL
5	NULL
,	NULL
.E	NULL
E	NULL
n	NULL
-	NULL
6	NULL
z	NULL
3	NULL
dons	NULL
=S	NULL
&	NULL
sa	NULL
A	NULL
8	NULL
I	NULL
>	NULL
.	NULL

B-5	NULL
19	NULL
s	NULL
2	NULL
4	NULL
10	NULL
0	NULL
g	NULL
9	NULL
C	NULL
<	NULL
J	NULL
50	NULL
[	NULL
5	NULL
&	NULL
«	NULL
=	NULL
'	NULL
3	NULL
2	NULL
4	NULL
050	NULL
$	NULL
£	NULL
o	NULL
m	NULL
&	NULL
it	NULL
o	NULL
4	NULL
00	NULL
Probe	NULL
--	NULL
-	NULL
»	NULL
L	NULL
A	NULL
sf	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
Fraction	NULL
Number	NULL
0.2	NULL
0.3	NULL
0.4	NULL
0.5	NULL
0.6	NULL
0.7	NULL
0.8	NULL
0.9	NULL
[	NULL
KCI	NULL
]	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

_	NULL
Purification	NULL
of	NULL
PRDIL	NULL
binding	NULL
activity	NULL
from	NULL
PMA	NULL
induced	NULL
Jurkat	NULL
T-cells	NULL
.	NULL

A	NULL
,	NULL
fractionation	NULL
by	NULL
Sephacryl	NULL
S-300	NULL
HR	NULL
gel	NULL
filtration	NULL
.	NULL

WCE	NULL
was	NULL
prepared	NULL
from	NULL
PMA	NULL
induced	NULL
Jurkat	NULL
T-cells	NULL
and	NULL
applied	NULL
to	NULL
a	NULL
DEAE-Sephacel	NULL
column	NULL
;	NULL
the	NULL
flow-through	NULL
0.5	NULL
m	NULL
KC	NULL
)	NULL
was	NULL
precipitated	NULL
with	NULL
70	NULL
%	NULL
ammonium	NULL
sulfate	NULL
.	NULL

The	NULL
precipitate	NULL
was	NULL
resuspended	NULL
in	NULL
buffer	NULL
Z	NULL
and	NULL
loaded	NULL
on	NULL
a	NULL
5-300	NULL
Sephacryl	NULL
column	NULL
.	NULL

Fractions	NULL
(	NULL
4	NULL
ml	NULL
)	NULL
were	NULL
collected	NULL
and	NULL
assayed	NULL
by	NULL
mobility	NULL
shift	NULL
assay	NULL
using	NULL
4	NULL
ag	NULL
of	NULL
protein	NULL
and	NULL
3	NULL
pg	NULL
of	NULL
poly	NULL
{	NULL
dh	NULL
:	NULL
dC	NULL
]	NULL
with	NULL
the	NULL
P2	NULL
probe	NULL
.	NULL

NS	NULL
,	NULL
nonspecific	NULL
binding	NULL
;	NULL
CE	NULL
,	NULL
crude	NULL
extract	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
;	NULL
DEAE	NULL
,	NULL
DEAE-Sephacel	NULL
flow-through	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
;	NULL
AS	NULL
,	NULL
ammonium	NULL
sulfate	NULL
precipitate	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
.	NULL

The	NULL
elution	NULL
profile	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
relative	NULL
to	NULL
the	NULL
total	NULL
protein	NULL
fraction	NULL
is	NULL
shown	NULL
below	NULL
the	NULL
figure	NULL
.	NULL

Hatched	NULL
bar	NULL
,	NULL
the	NULL
fractions	NULL
pooled	NULL
for	NULL
subsequent	NULL
purification	NULL
(	NULL
5-300	NULL
pool	NULL
)	NULL
.	NULL

8	NULL
,	NULL
DNA	NULL
affinity	NULL
column	NULL
chromatography	NULL
.	NULL

The	NULL
$	NULL
-300	NULL
pool	NULL
was	NULL
loaded	NULL
on	NULL
a	NULL
5-ml	NULL
heparin-Sepharose	NULL
column	NULL
equilibrated	NULL
with	NULL
0.1	NULL
m	NULL
KCl	NULL
;	NULL
the	NULL
active	NULL
fraction	NULL
eluting	NULL
from	NULL
the	NULL
column	NULL
at	NULL
0.6	NULL
m	NULL
KCI	NULL
was	NULL
diluted	NULL
to	NULL
0.1	NULL
m	NULL
KCI	NULL
with	NULL
buffer	NULL
Z	NULL
,	NULL
incubated	NULL
with	NULL
nonspecific	NULL
DNA	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
then	NULL
applied	NULL
to	NULL
a	NULL
specific	NULL
DNA	NULL
affinity	NULL
column	NULL
containing	NULL
multimerized	NULL
P2	NULL
oligonucleotides	NULL
.	NULL

Proteins	NULL
were	NULL
eluted	NULL
from	NULL
the	NULL
column	NULL
by	NULL
a	NULL
stepwise	NULL
gradient	NULL
of	NULL
KCI	NULL
,	NULL
and	NULL
5	NULL
al	NULL
of	NULL
each	NULL
fraction	NULL
were	NULL
tested	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
using	NULL
0.2	NULL
ng	NULL
**P-labeled	NULL
probe	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
exposed	NULL
to	NULL
film	NULL
for	NULL
1	NULL
h.	NULL
Table	NULL
1	NULL
Purification	NULL
of	NULL
PRUDI	NULL
binding	NULL
proteins	NULL
from	NULL
IFN	NULL
primed	NULL
,	NULL
cycloheximide/poly	NULL
{	NULL
rl	NULL
:	NULL
rC	NULL
]	NULL
induced	NULL
Hela	NULL
S3	NULL
cells	NULL
The	NULL
specific	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
in	NULL
the	NULL
protein-DNA	NULL
complex	NULL
(	NULL
determined	NULL
by	NULL
laser	NULL
densitometry	NULL
and	NULL
expressed	NULL
as	NULL
scanning	NULL
.	NULL

units	NULL
)	NULL
using	NULL
1	NULL
ag	NULL
of	NULL
protein	NULL
from	NULL
WCE	NULL
,	NULL
0.2	NULL
ng	NULL
of	NULL
the	NULL
P2	NULL
oligonucleotide	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
[	NULL
dl	NULL
:	NULL
dC	NULL
]	NULL
in	NULL
the	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
fold	NULL
purification	NULL
is	NULL
determined	NULL
by	NULL
dividing	NULL
the	NULL
specific	NULL
binding	NULL
activity	NULL
in	NULL
a	NULL
given	NULL
fraction	NULL
by	NULL
the	NULL
specific	NULL
activity	NULL
detected	NULL
in	NULL
1	NULL
ag	NULL
WCE	NULL
.	NULL

The	NULL
percentage	NULL
yield	NULL
is	NULL
the	NULL
total	NULL
activity	NULL
in	NULL
a	NULL
given	NULL
fraction	NULL
divided	NULL
by	NULL
the	NULL
total	NULL
activity	NULL
present	NULL
in	NULL
WCE	NULL
.	NULL

Fraction	NULL
Total	NULL
protein	NULL
Total	NULL
activity	NULL
Specific	NULL
activity	NULL
Fold	NULL
%	NULL
yield	NULL
at	NULL
(	NULL
mg	NULL
)	NULL
{	NULL
units	NULL
X	NULL
10°	NULL
)	NULL
(	NULL
units	NULL
X	NULL
10°/mg	NULL
)	NULL
purification	NULL
of	NULL
activity	NULL
Whole	NULL
cell	NULL
extract	NULL
920	NULL
150	NULL
0.16	NULL
1.0	NULL
100	NULL
Ammonium	NULL
sulfate	NULL
precipitate	NULL
412	NULL
115	NULL
0.28	NULL
1.75	NULL
77	NULL
Sephacryl	NULL
8-300	NULL
90	NULL
35	NULL
0.39	NULL
2.4	NULL
23	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
Cycle	NULL
1	NULL
0.86	NULL
30	NULL
35.1	NULL
220.0	NULL
20	NULL
Cycle	NULL
2	NULL
0.04	NULL
15.5	NULL
387.0	NULL
2,418.0	NULL
10.3	NULL
Cycle	NULL
3	NULL
0.004	NULL
10	NULL
2,520.0	NULL
15,750.0	NULL
6.6	NULL
to	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
breakdown	NULL
product	NULL
cross-linking	NULL
analysis	NULL
,	NULL
the	NULL
52	NULL
and	NULL
56	NULL
kD	NULL
factors	NULL
were	NULL
of	NULL
45	NULL
kD	NULL
,	NULL
respectively	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
Jurkat	NULL
fraction	NULL
DNA	NULL
binding	NULL
proteins	NULL
,	NULL
whereas	NULL
the	NULL
67	NULL
and	NULL
82	NULL
kD	NULL
pro-contained	NULL
additional	NULL
polypeptides	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Lane	NULL
3	NULL
)	NULL
of	NULL
67	NULL
teins	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
BrdUrd	NULL
substituted	NULL
P2	NULL
probe	NULL
and	NULL
82	NULL
kD	NULL
.	NULL

The	NULL
recovery	NULL
of	NULL
these	NULL
proteins	NULL
was	NULL
repro-	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

ducible	NULL
in	NULL
a	NULL
subsequent	NULL
purification	NULL
,	NULL
although	NULL
they	NULL
were	NULL
Purification	NULL
of	NULL
a	NULL
Cellular	NULL
Protein	NULL
Interacting	NULL
with	NULL
the	NULL
present	NULL
in	NULL
different	NULL
amounts	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Lane	NULL
4	NULL
)	NULL
.	NULL

By	NULL
UV-	NULL
PRDI	NULL
and	NULL
PRDill	NULL
Domains	NULL
.	NULL

Both	NULL
PRD	NULL
!	NULL

and	NULL
PRDIII	NULL
do	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
327	NULL
A.	NULL
Hela	NULL
S3	NULL
cells	NULL
B.	NULL
Jurkat	NULL
T	NULL
cells	NULL
A	NULL
``	NULL
=	NULL
lad	NULL
c	NULL
§	NULL
-	NULL
s	NULL
a.	NULL
g	NULL
‘	NULL
a.	NULL
E.	NULL
s	NULL
°	NULL
mw	NULL
g	NULL
°	NULL
3	NULL
a	NULL
5	NULL
(	NULL
kd	NULL
)	NULL
_	NULL
#	NULL
4	NULL
184	NULL
mw	NULL
(	NULL
kd	NULL
)	NULL
184	NULL
-	NULL
116	NULL
116	NULL
84	NULL
$	NULL
4	NULL
58	NULL
-	NULL
58	NULL
48.5	NULL
48.5	NULL
36.5	NULL
36.5	NULL
26.6	NULL
Lane	NULL
No	NULL
.	NULL

1	NULL
2	NULL
1	NULL
7	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Aff	NULL
.	NULL

cycle	NULL
3	NULL
3	NULL
C.	NULL
UV	NULL
crosslinking	NULL
4	NULL
e	NULL
SDS-polyacrylamide	NULL
gel	NULL
analysis	NULL
of	NULL
purified	NULL
fractions	NULL
.	NULL

A	NULL
,	NULL
Hela	NULL
S3	NULL
proteins	NULL
.	NULL

Proteins	NULL
from	NULL
the	NULL
$	NULL
-300	NULL
pool	NULL
(	NULL
10	NULL
ag	NULL
)	NULL
(	NULL
Lane	NULL
1	NULL
)	NULL
and	NULL
0.5	NULL
m	NULL
KCI	NULL
eluate	NULL
from	NULL
the	NULL
third	NULL
cycle	NULL
DNA	NULL
affinity	NULL
column	NULL
(	NULL
Aff.cycle	NULL
3	NULL
,	NULL
100	NULL
wl	NULL
)	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
were	NULL
precipitated	NULL
with	NULL
10	NULL
%	NULL
trichloroacetic	NULL
acid-0.15	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
resuspended	NULL
in	NULL
SDS-sample	NULL
buffer	NULL
,	NULL
and	NULL
run	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

Proteins	NULL
were	NULL
revealed	NULL
on	NULL
the	NULL
gel	NULL
by	NULL
silver	NULL
staining	NULL
.	NULL

B	NULL
,	NULL
Jurkat	NULL
T-cell	NULL
proteins	NULL
.	NULL

Proteins	NULL
from	NULL
the	NULL
heparin	NULL
pool	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
(	NULL
Lane	NULL
1	NULL
)	NULL
,	NULL
active	NULL
pool	NULL
eluted	NULL
from	NULL
the	NULL
DNA	NULL
affinity	NULL
column	NULL
at	NULL
0.5-0.6	NULL
m	NULL
KCI	NULL
after	NULL
the	NULL
second	NULL
cycle	NULL
(	NULL
Aff.cycle	NULL
2	NULL
,	NULL
500	NULL
ng	NULL
)	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
third	NULL
cycle	NULL
(	NULL
Aff.cycle	NULL
3	NULL
,	NULL
100	NULL
ul	NULL
)	NULL
(	NULL
Lane	NULL
3	NULL
)	NULL
were	NULL
analyzed	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

Lane	NULL
4	NULL
,	NULL
the	NULL
third	NULL
cycle	NULL
DNA	NULL
affinity	NULL
fraction	NULL
obtained	NULL
from	NULL
a	NULL
subsequent	NULL
purification	NULL
from	NULL
6-h	NULL
PMA	NULL
induced	NULL
Jurkat	NULL
cells	NULL
.	NULL

C	NULL
,	NULL
UV	NULL
cross-linking	NULL
of	NULL
Jurkat	NULL
T-cell	NULL
proteins	NULL
.	NULL

Forty	NULL
ng	NULL
of	NULL
protein	NULL
from	NULL
the	NULL
third	NULL
cycle	NULL
of	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
were	NULL
incubated	NULL
with	NULL
BrdUrd-P2	NULL
probe	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
and	NULL
UV	NULL
cross-linked	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Lane	NULL
1	NULL
,	NULL
no	NULL
competitor	NULL
DNA	NULL
;	NULL
Lane	NULL
2	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
P2	NULL
competitor	NULL
DNA	NULL
.	NULL

The	NULL
apparent	NULL
molecular	NULL
weights	NULL
correspond	NULL
to	NULL
the	NULL
mass	NULL
of	NULL
the	NULL
protein	NULL
DNA	NULL
cross-linked	NULL
complexes	NULL
(	NULL
the	NULL
mass	NULL
of	NULL
the	NULL
P2	NULL
BrdUrd	NULL
probe	NULL
is	NULL
13	NULL
kD	NULL
)	NULL
.	NULL

mains	NULL
of	NULL
the	NULL
IFN-8	NULL
promoter	NULL
contain	NULL
two	NULL
permutated	NULL
copies	NULL
of	NULL
the	NULL
hexamer	NULL
motif	NULL
AAGTGA	NULL
,	NULL
multimers	NULL
of	NULL
which	NULL
are	NULL
known	NULL
to	NULL
bind	NULL
the	NULL
IRF	NULL
proteins	NULL
and	NULL
PRDI-BF1	NULL
(	NULL
4	NULL
,	NULL
14	NULL
)	NULL
.	NULL

A	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
protein	NULL
extracts	NULL
from	NULL
-	NULL
uninduced	NULL
and	NULL
IFN/cycloheximide/	NULL
poly	NULL
[	NULL
I	NULL
:	NULL
C	NULL
]	NULL
induced	NULL
HeLa	NULL
S3	NULL
cells	NULL
,	NULL
using	NULL
the	NULL
radiolabeled	NULL
tetrahexamer	NULL
(	NULL
AAGTGA	NULL
)	NULL
,	NULL
oligonucleotide	NULL
as	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
uninduced	NULL
extracts	NULL
,	NULL
two	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
detected	NULL
(	NULL
complexes	NULL
|	NULL
and	NULL
II	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
Lanes	NULL
1-3	NULL
)	NULL
;	NULL
in	NULL
the	NULL
induced	NULL
extract	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
complex	NULL
1	NULL
was	NULL
decreased	NULL
about	NULL
5-fold	NULL
,	NULL
complex	NULL
I	NULL
!	NULL

was	NULL
not	NULL
detected	NULL
,	NULL
and	NULL
a	NULL
new	NULL
induction	NULL
specific	NULL
complex	NULL
(	NULL
complex	NULL
IIl	NULL
)	NULL
was	NULL
identified	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
Lanes	NULL
4-6	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
induction	NULL
specific	NULL
complex	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
IFN	NULL
primed	NULL
,	NULL
Sendai	NULL
virus	NULL
induced	NULL
protein	NULL
extracts	NULL
using	NULL
either	NULL
the	NULL
same	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
or	NULL
the	NULL
IFN-8	NULL
IRE	NULL
(	NULL
35	NULL
)	NULL
;	NULL
recent	NULL
experiments	NULL
demonstrate	NULL
that	NULL
complex	NULL
III	NULL
is	NULL
specifically	NULL
induced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
cycloheximide	NULL
and	NULL
poly	NULL
[	NULL
I	NULL
:	NULL
C	NULL
]	NULL
.	NULL
``	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
three	NULL
complexes	NULL
was	NULL
assessed	NULL
using	NULL
oligonucleotides	NULL
representing	NULL
different	NULL
IFN-8	NULL
promoter	NULL
domains	NULL
as	NULL
competitor	NULL
.	NULL

For	NULL
all	NULL
three	NULL
complexes	NULL
,	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
homologous	NULL
TH	NULL
oligonucleotide	NULL
competed	NULL
efficiently	NULL
for	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
Lanes	NULL
2	NULL
and	NULL
9	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
mutant	NULL
trihexamer	NULL
and	NULL
the	NULL
P2	NULL
(	NULL
PRD1	NULL
!	NULL
)	NULL

oligonucleotide	NULL
were	NULL
unable	NULL
to	NULL
compete	NULL
for	NULL
*J.	NULL
Wagner	NULL
and	NULL
L.	NULL
Cohen	NULL
,	NULL
unpublished	NULL
observations	NULL
.	NULL

binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
Lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
12	NULL
)	NULL
.	NULL

The	NULL
IRE	NULL
sequence	NULL
was	NULL
able	NULL
to	NULL
compete	NULL
more	NULL
effectively	NULL
than	NULL
the	NULL
P1	NULL
(	NULL
PRD1	NULL
)	NULL
oligonucleotide	NULL
for	NULL
the	NULL
three	NULL
complexes	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
4	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
and	NULL
14	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
sequences	NULL
surrounding	NULL
the	NULL
PRDI	NULL
domain	NULL
in	NULL
the	NULL
IRE	NULL
may	NULL
be	NULL
necessary	NULL
to	NULL
stabilize	NULL
complex	NULL
formation	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
P5	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
PRDIII	NULL
region	NULL
was	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
complex	NULL
II	NULL
!	NULL

formation	NULL
better	NULL
than	NULL
for	NULL
complex	NULL
|	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
Lanes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
11	NULL
,	NULL
and	NULL
13	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
specific	NULL
protein	NULL
which	NULL
generated	NULL
complex	NULL
III	NULL
was	NULL
purified	NULL
from	NULL
cycloheximide/poly	NULL
[	NULL
I	NULL
:	NULL
C	NULL
]	NULL
induced	NULL
HeLa	NULL
cell	NULL
extracts	NULL
following	NULL
essentially	NULL
the	NULL
same	NULL
purification	NULL
scheme	NULL
as	NULL
described	NULL
above	NULL
for	NULL
the	NULL
PRDII/	NULL
«	NULL
kB	NULL
binding	NULL
factors	NULL
.	NULL

The	NULL
$	NULL
-300	NULL
fractions	NULL
containing	NULL
TH	NULL
binding	NULL
activity	NULL
were	NULL
pooled	NULL
and	NULL
subjected	NULL
to	NULL
three	NULL
cycles	NULL
of	NULL
TH	NULL
specific	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
.	NULL

Fig	NULL
.	NULL

5C	NULL
shows	NULL
that	NULL
the	NULL
protein	NULL
responsible	NULL
for	NULL
complex	NULL
IIl	NULL
formation	NULL
eluted	NULL
from	NULL
the	NULL
DNA	NULL
affinity	NULL
column	NULL
at	NULL
high	NULL
salt	NULL
concentration	NULL
(	NULL
0.7	NULL
and	NULL
0.8	NULL
m	NULL
KCl	NULL
)	NULL
.	NULL

SDS-polyacrylamide	NULL
gel	NULL
analysis	NULL
of	NULL
the	NULL
recovered	NULL
fraction	NULL
revealed	NULL
a	NULL
polypeptide	NULL
of	NULL
56	NULL
kD	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
similarities	NULL
in	NULL
DNA	NULL
binding	NULL
specificity	NULL
and	NULL
molecular	NULL
weight	NULL
of	NULL
the	NULL
TH	NULL
protein	NULL
and	NULL
the	NULL
IRF-1/ISGF-2	NULL
protein	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
the	NULL
TH	NULL
fraction	NULL
was	NULL
compared	NULL
to	NULL
in	NULL
vitro	NULL
translated	NULL
IRF-1	NULL
by	NULL
Western	NULL
immu-noblot	NULL
analysis	NULL
,	NULL
using	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
raised	NULL
against	NULL
ISGF-2	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
antibody	NULL
specifically	NULL
recognized	NULL
the	NULL
in	NULL
vitro	NULL
translated	NULL
53	NULL
kD	NULL
IRF-1	NULL
protein	NULL
but	NULL
did	NULL
not	NULL
react	NULL
with	NULL
DNA	NULL
affinity	NULL
purified	NULL
TH	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

56	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
TH	NULL
protein	NULL
was	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
distinct	NULL
from	NULL
IRF	NULL
328	NULL
IFN-	NULL
Protein-DNA	NULL
Interactions	NULL
A	NULL
Uninduced	NULL
Induced	NULL
B	NULL
Uninduced	NULL
(	NULL
81g	NULL
)	NULL
Induced	NULL
Io	NULL
2	NULL
3	NULL
4	NULL
5006	NULL
Io	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
coo	NULL
stip	NULL
ne	NULL
i-	NULL
tou	NULL
~	NULL
gu	NULL
ta	NULL
Ah	NULL
at	NULL
o	NULL
nn	NULL
n	NULL
00	NULL
111	NULL
-	NULL
»	NULL
ws	NULL
HII	NULL
-	NULL
»	NULL
.	NULL

m	NULL
>	NULL
P	NULL
-	NULL
»	NULL
p-	NULL
»	NULL
Competitor	NULL
DNA	NULL
--	NULL
TH	NULL
Tn	NULL
PL	NULL
P2	NULL
P5	NULL
IRE	NULL
-	NULL
TH	NULL
Tn	NULL
P1	NULL
P2	NULL
P5	NULL
IRE	NULL
C	NULL
D	NULL
-	NULL
E	NULL
_	NULL
_	NULL
y	NULL
3	NULL
3	NULL
T	NULL
5	NULL
,	NULL
<	NULL
Aa	NULL
M	NULL
KCI	NULL
Elution	NULL
>	NULL
-	NULL
§	NULL
a	NULL
z	NULL
a	NULL
)	NULL
FT	NULL
wWi'02	NULL
0.3	NULL
0.4	NULL
0.5	NULL
0.6	NULL
0.7	NULL
0.8	NULL
%	NULL
0.9	NULL
1.0	NULL
a	NULL
#	NULL
<	NULL
sen	NULL
mmm	NULL
mme	NULL
omer	NULL
opm	NULL
tmm	NULL
ome	NULL
nem	NULL
mens	NULL
sm	NULL
-	NULL
66	NULL
53	NULL
kd	NULL
>	NULL
-+	NULL
-	NULL
45	NULL
-	NULL
36	NULL
-	NULL
29	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Inducibility	NULL
of	NULL
TH	NULL
binding	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
titration	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Two	NULL
,	NULL
4	NULL
,	NULL
and	NULL
8	NULL
ag	NULL
of	NULL
uninduced	NULL
(	NULL
Lanes	NULL
1-3	NULL
)	NULL
or	NULL
IFN/cycloheximide/poly	NULL
[	NULL
1	NULL
:	NULL
C	NULL
]	NULL
induced	NULL
(	NULL
Lanes	NULL
4-6	NULL
)	NULL
WCE	NULL
from	NULL
HeLa	NULL
$	NULL
3	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
tetrahexamer	NULL
oligonucleotide	NULL
(	NULL
TH	NULL
probe	NULL
)	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
poly	NULL
{	NULL
dl	NULL
:	NULL
dC	NULL
)	NULL
.	NULL

1	NULL
,	NULL
H/	NULL
,	NULL
I	NULL
!	NULL

,	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
;	NULL
P	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
competition	NULL
analysis	NULL
.	NULL

Eight	NULL
ug	NULL
of	NULL
uninduced	NULL
(	NULL
Lanes	NULL
1-7	NULL
)	NULL
or	NULL
induced	NULL
(	NULL
Lanes	NULL
8-14	NULL
)	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
no	NULL
competitor	NULL
(	NULL
Lanes	NULL
1	NULL
and	NULL
8	NULL
)	NULL
or	NULL
50	NULL
ng	NULL
of	NULL
different	NULL
oligonucleotides	NULL
as	NULL
listed	NULL
betow	NULL
the	NULL
figure	NULL
.	NULL

C	NULL
,	NULL
DNA	NULL
affinity	NULL
column	NULL
chromatography	NULL
.	NULL

Fractions	NULL
eluted	NULL
from	NULL
the	NULL
S-300	NULL
Sephacryl	NULL
column	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
were	NULL
tested	NULL
for	NULL
TH	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
active	NULL
pool	NULL
(	NULL
--	NULL
)	NULL
was	NULL
subsequently	NULL
purified	NULL
over	NULL
3	NULL
cycles	NULL
of	NULL
TH-DNA	NULL
affinity	NULL
column	NULL
chromatography	NULL
.	NULL

Fractions	NULL
(	NULL
10	NULL
wl	NULL
)	NULL
eluted	NULL
from	NULL
the	NULL
third	NULL
cycle	NULL
were	NULL
assayed	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
poly	NULL
{	NULL
dI	NULL
:	NULL
dC	NULL
]	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

The	NULL
0.7	NULL
and	NULL
0.8	NULL
m	NULL
KCI	NULL
fractions	NULL
were	NULL
highly	NULL
enriched	NULL
for	NULL
complex	NULL
III	NULL
binding	NULL
activity	NULL
,	NULL
and	NULL
these	NULL
fractions	NULL
were	NULL
pooled	NULL
.	NULL

A	NULL
shifted	NULL
band	NULL
appeared	NULL
in	NULL
the	NULL
0.8	NULL
m	NULL
KCI	NULL
eluate	NULL
that	NULL
did	NULL
not	NULL
correspond	NULL
to	NULL
complex	NULL
I	NULL
(	NULL
arrowheads	NULL
)	NULL
.	NULL

D	NULL
,	NULL
SDS-polyacrylamide	NULL
gel	NULL
analysis	NULL
of	NULL
purified	NULL
fraction	NULL
.	NULL

WCE	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
,	NULL
AS	NULL
precipitate	NULL
(	NULL
10	NULL
ag	NULL
)	NULL
,	NULL
and	NULL
100	NULL
al	NULL
of	NULL
the	NULL
TH	NULL
purified	NULL
fraction	NULL
were	NULL
analyzed	NULL
by	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Arrowhead	NULL
,	NULL
nonspecific	NULL
staining	NULL
.	NULL

£	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Proteins	NULL
were	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

-	NULL
,	NULL
10	NULL
«	NULL
l	NULL
of	NULL
wheat	NULL
germ	NULL
extract	NULL
alone	NULL
;	NULL
IRF-1	NULL
,	NULL
10	NULL
gl	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
IRF-1	NULL
;	NULL
TH	NULL
,	NULL
500	NULL
ng	NULL
of	NULL
affinity	NULL
purified	NULL
TH	NULL
protein	NULL
(	NULL
first	NULL
cycle	NULL
of	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
)	NULL
.	NULL

1/ISGF-2	NULL
.	NULL

Recent	NULL
UV	NULL
cross-linking	NULL
analysis	NULL
indicates	NULL
that	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
was	NULL
established	NULL
in	NULL
which	NULL
the	NULL
TH	NULL
DNA	NULL
binding	NULL
subunit	NULL
is	NULL
a	NULL
polypeptide	NULL
of	NULL
14	NULL
kD	NULL
the	NULL
transcript	NULL
level	NULL
from	NULL
the	NULL
IFN-8	NULL
DNA	NULL
gene	NULL
template	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

was	NULL
compared	NULL
with	NULL
that	NULL
from	NULL
a	NULL
control	NULL
rabbit	NULL
B-globin	NULL
In	NULL
Vitro	NULL
Transcription	NULL
of	NULL
the	NULL
IFN-8	NULL
Gene	NULL
.	NULL

To	NULL
examine	NULL
gene	NULL
.	NULL

High	NULL
efficiency	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
the	NULL
effects	NULL
of	NULL
purified	NULL
proteins	NULL
on	NULL
IFN-8	NULL
gene	NULL
expression	NULL
,	NULL
from	NULL
uninduced	NULL
or	NULL
from	NULL
Sendai	NULL
virus	NULL
induced	NULL
Hela	NULL
S3	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

A	NULL
,	NULL
in	NULL
vitro	NULL
transcription	NULL
of	NULL
IFN-B	NULL
Probe	NULL
-	NULL
»	NULL
truncated	NULL
IFN-8	NULL
promoter	NULL
templates	NULL
.	NULL

Transcription	NULL
reactions	NULL
(	NULL
40	NULL
ul	NULL
)	NULL
containing	NULL
500	NULL
ng	NULL
of	NULL
the	NULL
IFN-8	NULL
plasmid	NULL
template	NULL
,	NULL
250	NULL
ng	NULL
of	NULL
rabbit	NULL
B-globin	NULL
plasmid	NULL
(	NULL
RBG	NULL
)	NULL
,	NULL
and	NULL
2	NULL
ug/	NULL
ul	NULL
nuclear	NULL
extract	NULL
from	NULL
uninduced	NULL
{	NULL
Lanes	NULL
3-9	NULL
)	NULL
or	NULL
IFN/Sendai	NULL
virus	NULL
induced	NULL
(	NULL
Lanes	NULL
10-16	NULL
)	NULL
HeLa	NULL
S3	NULL
cells	NULL
.	NULL

Numbers	NULL
below	NULL
the	NULL
figures	NULL
correspond	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
point	NULL
of	NULL
truncated	NULL
IFN-8	NULL
plasmids	NULL
.	NULL

Correctly	NULL
initiated	NULL
transcripts	NULL
(	NULL
C.J	NULL
.	NULL

transcript	NULL
)	NULL
corresponding	NULL
to	NULL
IFN-8	NULL
and	NULL
RSG	NULL
mRNA	NULL
were	NULL
measured	NULL
by	NULL
St	NULL
mapping	NULL
using	NULL
the	NULL
922-bp	NULL
Bg/ll-EcoR|	NULL
IFN-8	NULL
probe	NULL
and	NULL
the	NULL
575-bp	NULL
BamHI-Pstl	NULL
RBG	NULL
probe	NULL
.	NULL

Read	NULL
through	NULL
transcripts	NULL
from	NULL
the	NULL
IFN-8	NULL
templates	NULL
are	NULL
also	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
the	NULL
8	NULL
587	NULL
RBG	NULL
Probe	NULL
-	NULL
»	NULL
458	NULL
434	NULL
UNINDUCED	NULL
SENDALINDUCED	NULL
I87-	NULL
6	NULL
Read	NULL
Through	NULL
Transcript	NULL
-+	NULL
IFN-B	NULL
C.1	NULL
.	NULL

Transcript	NULL
cams	NULL
cts	NULL
.	NULL

cot	NULL
PU	NULL
W	NULL
ms	NULL
,	NULL
.	NULL

=	NULL
a	NULL
RC	NULL
C.1	NULL
.	NULL

Transcript	NULL
PEL	NULL
$	NULL
8	NULL
L9	NULL
95	NULL
PE-€€-	NULL
187	NULL
PEI	NULL
S8	NULL
L9	NULL
relative	NULL
transcript	NULL
levels	NULL
obtained	NULL
by	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
autoradiograph	NULL
shown	NULL
in	NULL
A	NULL
.	NULL

The	NULL
relative	NULL
transcript	NULL
levels	NULL
represent	NULL
the	NULL
IFN-8	NULL
to	NULL
RBG	NULL
signal	NULL
ratios	NULL
,	NULL
with	NULL
the	NULL
IFN-6	NULL
:	NULL
R8G	NULL
ratio	NULL
obtained	NULL
for	NULL
the	NULL
-281	NULL
template	NULL
in	NULL
uninduced	NULL
extract	NULL
taken	NULL
as	NULL
arbitrary	NULL
unit	NULL
of	NULL
1	NULL
.	NULL

Relative	NULL
Transcript	NULL
Level	NULL
J	NULL
I	NULL
Uninduced	NULL
|	NULL
WBB	NULL
Sendai	NULL
induced	NULL
-281	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
and	NULL
used	NULL
to	NULL
transcribe	NULL
a	NULL
series	NULL
of	NULL
IFN-8	NULL
promoter	NULL
deletions	NULL
that	NULL
progressively	NULL
disrupted	NULL
IFN-8	NULL
regulatory	NULL
elements	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Correctly	NULL
initiated	NULL
RNA	NULL
and	NULL
read	NULL
through	NULL
transcripts	NULL
were	NULL
distinguished	NULL
by	NULL
an	NULL
S1	NULL
nuclease	NULL
mapping	NULL
procedure	NULL
(	NULL
37	NULL
)	NULL
.	NULL

In	NULL
uninduced	NULL
HeLa	NULL
S3	NULL
nuclear	NULL
extracts	NULL
,	NULL
a	NULL
low	NULL
level	NULL
of	NULL
correctly	NULL
initiated	NULL
transcripts	NULL
from	NULL
the	NULL
entire	NULL
IFN-8	NULL
promoter	NULL
(	NULL
-281	NULL
deletion	NULL
)	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Lane	NULL
3	NULL
)	NULL
.	NULL

IFN-8	NULL
promoter	NULL
deletions	NULL
ending	NULL
at	NULL
-134	NULL
and	NULL
-85	NULL
did	NULL
not	NULL
change	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
correctly	NULL
initiated	NULL
IFN-8	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
;	NULL
however	NULL
,	NULL
deletion	NULL
to	NULL
-67	NULL
caused	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
IFN-8	NULL
specific	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Further	NULL
deletion	NULL
into	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
(	NULL
-34	NULL
and	NULL
-33	NULL
end	NULL
points	NULL
)	NULL
completely	NULL
abrogated	NULL
correctly	NULL
initiated	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
TATA	NULL
box	NULL
alone	NULL
was	NULL
not	NULL
sufficient	NULL
for	NULL
IFN-8	NULL
promoter	NULL
expression	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
IFN	NULL
primed	NULL
,	NULL
Sendai	NULL
virus	NULL
induced	NULL
extracts	NULL
,	NULL
transcription	NULL
from	NULL
the	NULL
-281	NULL
template	NULL
was	NULL
increased	NULL
relative	NULL
to	NULL
RBG	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Lane	NULL
10	NULL
)	NULL
,	NULL
corresponding	NULL
to	NULL
a	NULL
2-fold	NULL
increase	NULL
in	NULL
transcription	NULL
in	NULL
the	NULL
induced	NULL
extract	NULL
compared	NULL
to	NULL
the	NULL
uninduced	NULL
extract	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Lanes	NULL
3	NULL
and	NULL
10	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Deletion	NULL
to	NULL
-134	NULL
caused	NULL
a	NULL
2-fold	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Lane	NULL
11	NULL
)	NULL
,	NULL
whereas	NULL
further	NULL
deletion	NULL
of	NULL
sequences	NULL
previously	NULL
characterized	NULL
as	NULL
positive	NULL
regulatory	NULL
domains	NULL
in	NULL
vivo	NULL
in	NULL
the	NULL
region	NULL
between	NULL
-85	NULL
and	NULL
-67	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
induced	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Lanes	NULL
12	NULL
and	NULL
13	NULL
)	NULL
.	NULL

No	NULL
correctly	NULL
initiated	NULL
transcription	NULL
occurred	NULL
with	NULL
the	NULL
-34	NULL
and	NULL
-33	NULL
Deletion	NULL
End	NULL
Point	NULL
templates	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Lanes	NULL
15	NULL
and	NULL
16	NULL
)	NULL
,	NULL
confirming	NULL
that	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
sequence	NULL
were	NULL
required	NULL
for	NULL
basal	NULL
expression	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
transcription	NULL
of	NULL
the	NULL
-56	NULL
template	NULL
was	NULL
increased	NULL
about	NULL
5-fold	NULL
in	NULL
the	NULL
induced	NULL
extract	NULL
,	NULL
to	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
uninduced	NULL
extract	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Lanes	NULL
7	NULL
and	NULL
14	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
transcript	NULL
levels	NULL
obtained	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
for	NULL
the	NULL
different	NULL
IFN-8	NULL
promoter	NULL
deletions	NULL
is	NULL
quantified	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
-281	NULL
,	NULL
-134	NULL
,	NULL
and	NULL
-85	NULL
promoters	NULL
was	NULL
increased	NULL
in	NULL
the	NULL
induced	NULL
versus	NULL
uninduced	NULL
extracts	NULL
,	NULL
and	NULL
maximal	NULL
inducibility	NULL
(	NULL
4-fold	NULL
)	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
-134	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
high	NULL
level	NULL
transcription	NULL
of	NULL
the	NULL
-67	NULL
and	NULL
-56	NULL
promoters	NULL
occurred	NULL
in	NULL
uninduced	NULL
extracts	NULL
,	NULL
and	NULL
this	NULL
level	NULL
was	NULL
not	NULL
further	NULL
increased	NULL
in	NULL
the	NULL
induced	NULL
extracts	NULL
.	NULL

Four	NULL
independent	NULL
preparations	NULL
of	NULL
uninduced	NULL
extract	NULL
were	NULL
also	NULL
examined	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
support	NULL
IFN-8	NULL
specific	NULL
transcription	NULL
in	NULL
vitro	NULL
and	NULL
demonstrated	NULL
that	NULL
deletion	NULL
of	NULL
sequences	NULL
from	NULL
-281	NULL
to	NULL
=-111	NULL
progressively	NULL
increased	NULL
IFN-8	NULL
transcription	NULL
about	NULL
5-fold	NULL
,	NULL
confirming	NULL
a	NULL
dominant	NULL
negative	NULL
regulatory	NULL
effect	NULL
of	NULL
these	NULL
sequences	NULL
on	NULL
transcription	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PRDIH	NULL
and	NULL
TH	NULL
binding	NULL
proteins	NULL
on	NULL
IFN-8	NULL
transcription	NULL
in	NULL
vitro	NULL
was	NULL
examined	NULL
using	NULL
the	NULL
-134	NULL
and	NULL
-56	NULL
deletion	NULL
templates	NULL
in	NULL
the	NULL
IFN/Sendai	NULL
stimulated	NULL
extracts	NULL
.	NULL

Addition	NULL
of	NULL
the	NULL
fraction	NULL
containing	NULL
predominantly	NULL
the	NULL
52	NULL
and	NULL
56	NULL
kD	NULL
DNA	NULL
binding	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
2-fold	NULL
stimulation	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
-134	NULL
template	NULL
but	NULL
not	NULL
from	NULL
the	NULL
RBG	NULL
template	NULL
329	NULL
330	NULL
IFPN-s	NULL
Protein-DNA	NULL
Interactions	NULL
M	NULL
I	NULL
2	NULL
3	NULL
0	NULL
40	NULL
5	NULL
60	NULL
1708	NULL
9	NULL
IFN-B	NULL
-	NULL
»	NULL
<	NULL
a	NULL
``	NULL
%	NULL
Probe	NULL
it	NULL
®	NULL
muons	NULL
.	NULL

#	NULL
0	NULL
587.	NULL
stove	NULL
:	NULL
AA	NULL
is	NULL
maen	NULL
**	NULL
``	NULL
~-RBG	NULL
-m	NULL
.	NULL

Probe	NULL
«	NULL
ey	NULL
dun	NULL
wam	NULL
#	NULL
4	NULL
=~	NULL
458	NULL
434	NULL
~	NULL
PE	NULL
!	NULL

~	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
Lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
)	NULL
;	NULL
a	NULL
similar	NULL
2-fold	NULL
increase	NULL
was	NULL
observed	NULL
when	NULL
5	NULL
ul	NULL
(	NULL
corresponding	NULL
to	NULL
~10	NULL
ng	NULL
)	NULL
of	NULL
purified	NULL
TH	NULL
binding	NULL
protein	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
but	NULL
not	NULL
when	NULL
10	NULL
ul	NULL
of	NULL
the	NULL
fraction	NULL
were	NULL
added	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
Lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
both	NULL
fractions	NULL
was	NULL
additive	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
4-fold	NULL
increase	NULL
in	NULL
transcription	NULL
of	NULL
the	NULL
-134	NULL
template	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
Lane	NULL
8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
addition	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
TH	NULL
protein	NULL
again	NULL
reduced	NULL
the	NULL
transcript	NULL
level	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
Lane	NULL
9	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
stoichiometry	NULL
of	NULL
this	NULL
protein	NULL
with	NULL
other	NULL
factors	NULL
may	NULL
be	NULL
important	NULL
for	NULL
its	NULL
functional	NULL
activity	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
IFN-8	NULL
to	NULL
RBG	NULL
transcripts	NULL
was	NULL
not	NULL
altered	NULL
when	NULL
both	NULL
purified	NULL
fractions	NULL
were	NULL
used	NULL
together	NULL
with	NULL
the	NULL
-56	NULL
template	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
Lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
,	NULL
thus	NULL
demonstrating	NULL
the	NULL
requirement	NULL
for	NULL
protein	NULL
binding	NULL
sequences	NULL
between	NULL
-134	NULL
and	NULL
-56	NULL
of	NULL
the	NULL
IFN-8	NULL
promoter	NULL
.	NULL

Discussion	NULL
The	NULL
results	NULL
of	NULL
the	NULL
present	NULL
study	NULL
represent	NULL
the	NULL
first	NULL
utilization	NULL
of	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
to	NULL
characterize	NULL
purified	NULL
transcription	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
interferon	NULL
8	NULL
promoter	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
complexity	NULL
of	NULL
interferon	NULL
gene	NULL
regulation	NULL
(	NULL
1-14	NULL
,	NULL
35	NULL
,	NULL
38-41	NULL
)	NULL
,	NULL
in	NULL
vitro	NULL
dissection	NULL
of	NULL
the	NULL
protein-DNA	NULL
interactions	NULL
mediating	NULL
IFN-8	NULL
expression	NULL
may	NULL
be	NULL
essential	NULL
to	NULL
an	NULL
understanding	NULL
of	NULL
the	NULL
induction	NULL
process	NULL
.	NULL

As	NULL
a	NULL
first	NULL
step	NULL
in	NULL
reconstructing	NULL
IFN-8	NULL
transcription	NULL
in	NULL
vitro	NULL
,	NULL
induction	NULL
specific	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
PRDL	NULL
and	NULL
PRDII	NULL
regions	NULL
of	NULL
the	NULL
promoter	NULL
were	NULL
purified	NULL
and	NULL
examined	NULL
for	NULL
transcriptional	NULL
activity	NULL
in	NULL
vitro	NULL
.	NULL

Previous	NULL
experiments	NULL
had	NULL
demonstrated	NULL
that	NULL
the	NULL
inducible	NULL
PRDII	NULL
binding	NULL
protein	NULL
was	NULL
indistinguishable	NULL
from	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
19-22	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
purified	NULL
NF-	NULL
«	NULL
B-like	NULL
PRDH	NULL
binding	NULL
proteins	NULL
from	NULL
HeLa	NULL
$	NULL
3	NULL
cells	NULL
induced	NULL
with	NULL
cycloheximide/poly	NULL
[	NULL
I	NULL
:	NULL
C	NULL
]	NULL
and	NULL
from	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

From	NULL
HeLa	NULL
cells	NULL
,	NULL
PRDIE	NULL
binding	NULL
activity	NULL
was	NULL
about	NULL
5-fold	NULL
inducible	NULL
by	NULL
and	NULL
purified	NULL
as	NULL
two	NULL
polypeptides	NULL
of	NULL
52	NULL
and	NULL
45	NULL
kD	NULL
,	NULL
probably	NULL
identical	NULL
to	NULL
the	NULL
p50	NULL
and	NULL
p45	NULL
DNA	NULL
binding	NULL
proteins	NULL
identified	NULL
by	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
from	NULL
phorbol	NULL
ester	NULL
induced	NULL
Jurkat	NULL
cells	NULL
resolved	NULL
as	NULL
multiple	NULL
protein-DNA	NULL
complexes	NULL
in	NULL
the	NULL
mobility	NULL
shift	NULL
assay	NULL
and	NULL
copurified	NULL
with	NULL
polypeptides	NULL
of	NULL
82	NULL
,	NULL
67	NULL
,	NULL
52	NULL
,	NULL
and	NULL
43-47	NULL
kD	NULL
.	NULL

The	NULL
purification	NULL
of	NULL
these	NULL
proteins	NULL
is	NULL
particularly	NULL
relevant	NULL
since	NULL
recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
corresponds	NULL
to	NULL
a	NULL
family	NULL
of	NULL
four	NULL
distinct	NULL
DNA	NULL
binding	NULL
proteins	NULL
of	NULL
50	NULL
,	NULL
55	NULL
,	NULL
75	NULL
,	NULL
and	NULL
85	NULL
kD	NULL
(	NULL
29	NULL
,	NULL
33	NULL
)	NULL
,	NULL
all	NULL
of	NULL
which	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

-	NULL
Reconstitution	NULL
of	NULL
IFN-10	NULL
11	NULL
.	NULL

promoter	NULL
activation	NULL
.	NULL

Transcription	NULL
reactions	NULL
(	NULL
50	NULL
wl	NULL
)	NULL
contained	NULL
500	NULL
ng	NULL
of	NULL
plasmids	NULL
p802	NULL
(	NULL
~134/+1	NULL
start	NULL
site	NULL
)	NULL
(	NULL
Lanes	NULL
3-9	NULL
)	NULL
or	NULL
500	NULL
ng	NULL
of	NULL
p901	NULL
(	NULL
-56/+1	NULL
)	NULL
(	NULL
Lanes	NULL
10	NULL
and	NULL
17	NULL
)	NULL
,	NULL
and	NULL
250	NULL
ng	NULL
of	NULL
RBG	NULL
plasmid	NULL
.	NULL

Nuclear	NULL
extract	NULL
from	NULL
IFN/Sendai	NULL
HeLa	NULL
S3	NULL
cells	NULL
(	NULL
1.5	NULL
ug/al	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
general	NULL
transcription	NULL
factors	NULL
with	NULL
no	NULL
addition	NULL
(	NULL
Lanes	NULL
3	NULL
and	NULL
10	NULL
)	NULL
or	NULL
addition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
and	NULL
TH	NULL
binding	NULL
protein	NULL
as	NULL
follows	NULL
:	NULL
Lanes	NULL
4	NULL
and	NULL
5	NULL
,	NULL
5	NULL
and	NULL
10	NULL
al	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
respectively	NULL
;	NULL
Lanes	NULL
6	NULL
and	NULL
7	NULL
,	NULL
5	NULL
and	NULL
10	NULL
ul	NULL
of	NULL
TH	NULL
fraction	NULL
,	NULL
respectively	NULL
;	NULL
Lane	NULL
8	NULL
,	NULL
5	NULL
ul	NULL
of	NULL
NF-	NULL
«	NULL
8	NULL
and	NULL
5	NULL
ul	NULL
of	NULL
TH	NULL
;	NULL
Lanes	NULL
9	NULL
and	NULL
11	NULL
,	NULL
10	NULL
al	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
10	NULL
gl	NULL
of	NULL
TH	NULL
.	NULL

Read	NULL
Through	NULL
Transcript	NULL
-all	NULL
IFN-B	NULL
RNA	NULL
-all	NULL
RBG	NULL
RNA	NULL
95	NULL
are	NULL
antigenically	NULL
related	NULL
to	NULL
the	NULL
rel	NULL
family	NULL
of	NULL
oncoproteins	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
exact	NULL
relationship	NULL
between	NULL
the	NULL
polypeptides	NULL
isolated	NULL
in	NULL
this	NULL
study	NULL
and	NULL
the	NULL
recently	NULL
identified	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/rel	NULL
family	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
;	NULL
however	NULL
,	NULL
based	NULL
on	NULL
molecular	NULL
weight	NULL
,	NULL
the	NULL
82	NULL
kD	NULL
protein	NULL
appears	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
the	NULL
human	NULL
c-rel/p85	NULL
protein	NULL
identified	NULL
by	NULL
Molitor	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
,	NULL
33	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
67	NULL
and	NULL
52	NULL
kD	NULL
proteins	NULL
may	NULL
represent	NULL
the	NULL
p65	NULL
and	NULL
p50	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
26-28	NULL
)	NULL
.	NULL

The	NULL
differential	NULL
inducibility	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
proteins	NULL
from	NULL
HeLa	NULL
and	NULL
Jurkat	NULL
cells	NULL
,	NULL
as	NULL
reflected	NULL
in	NULL
distinct	NULL
molecular	NULL
weight	NULL
protein	NULL
species	NULL
,	NULL
is	NULL
an	NULL
intriguing	NULL
observation	NULL
that	NULL
may	NULL
have	NULL
physiological	NULL
relevance	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
interferon	NULL
8	NULL
and	NULL
other	NULL
NF-	NULL
«	NULL
B	NULL
regulated	NULL
genes	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
may	NULL
vary	NULL
significantly	NULL
with	NULL
the	NULL
cell	NULL
type	NULL
or	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
inducer	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
differential	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
dependent	NULL
transcription	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Temporal	NULL
variations	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/rel	NULL
family	NULL
could	NULL
also	NULL
contribute	NULL
to	NULL
differences	NULL
in	NULL
the	NULL
yield	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
from	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
by	NULL
phorbol	NULL
esters	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
a	NULL
biphasic	NULL
pattern	NULL
of	NULL
nuclear	NULL
expression	NULL
with	NULL
55	NULL
and	NULL
75	NULL
kD	NULL
species	NULL
appearing	NULL
within	NULL
minutes	NULL
and	NULL
50	NULL
and	NULL
85	NULL
kD	NULL
species	NULL
appearing	NULL
after	NULL
several	NULL
hours	NULL
of	NULL
cellular	NULL
induction	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
combinatorial	NULL
associations	NULL
between	NULL
distinct	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
may	NULL
contribute	NULL
to	NULL
negative	NULL
regulation	NULL
as	NULL
well	NULL
as	NULL
positive	NULL
transcriptional	NULL
activation	NULL
via	NULL
competition	NULL
between	NULL
factors	NULL
at	NULL
the	NULL
level	NULL
of	NULL
DNA	NULL
binding	NULL
.	NULL

The	NULL
v-rel	NULL
protein	NULL
has	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
been	NULL
shown	NULL
to	NULL
function	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
dependent	NULL
activation	NULL
,	NULL
whereas	NULL
nontrans-forming	NULL
mutants	NULL
of	NULL
v-rel	NULL
fail	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
mediated	NULL
transcription	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Human	NULL
c-rel	NULL
could	NULL
play	NULL
a	NULL
similar	NULL
role	NULL
in	NULL
regulation	NULL
of	NULL
interferon	NULL
8	NULL
and	NULL
other	NULL
NF-	NULL
«	NULL
B	NULL
mediated	NULL
genes	NULL
,	NULL
since	NULL
the	NULL
p85/c-rel	NULL
protein	NULL
normally	NULL
appears	NULL
in	NULL
the	NULL
nucleus	NULL
several	NULL
hours	NULL
after	NULL
induction	NULL
(	NULL
29	NULL
,	NULL
33	NULL
)	NULL
at	NULL
a	NULL
time	NULL
coincident	NULL
with	NULL
the	NULL
transcriptional	NULL
repression	NULL
of	NULL
many	NULL
NF-	NULL
«	NULL
B	NULL
mediated	NULL
cytokine	NULL
genes	NULL
(	NULL
14	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Alterna-tively	NULL
,	NULL
p85/c-rel	NULL
could	NULL
uncouple	NULL
the	NULL
normal	NULL
activation	NULL
pathway	NULL
by	NULL
protein-protein	NULL
interactions	NULL
which	NULL
interfere	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
p65-p50	NULL
heterodimer	NULL
activation	NULL
complex	NULL
(	NULL
26-28	NULL
)	NULL
or	NULL
by	NULL
acting	NULL
as	NULL
an	NULL
IkB	NULL
analogue	NULL
(	NULL
33	NULL
)	NULL
.	NULL

These	NULL
possibilities	NULL
will	NULL
require	NULL
further	NULL
analysis	NULL
.	NULL

A	NULL
second	NULL
DNA	NULL
binding	NULL
protein	NULL
(	NULL
TH	NULL
)	NULL
,	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
the	NULL
PRD	NULL
!	NULL

and	NULL
PRDII	NULL
domains	NULL
of	NULL
the	NULL
IFN-8	NULL
promoter	NULL
,	NULL
was	NULL
also	NULL
purified	NULL
from	NULL
IFN/cycloheximide/	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
331	NULL
poly	NULL
[	NULL
I	NULL
:	NULL
C	NULL
]	NULL
induced	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
TH	NULL
protein	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
uninduced	NULL
cells	NULL
and	NULL
was	NULL
activated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
protein	NULL
synthesis	NULL
,	NULL
reminiscent	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
factor	NULL
PRDI-BFi	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
immunological	NULL
studies	NULL
demonstrate	NULL
that	NULL
the	NULL
TH	NULL
protein	NULL
is	NULL
not	NULL
IRF-1/ISGF-2	NULL
,	NULL
although	NULL
the	NULL
two	NULL
proteins	NULL
have	NULL
similar	NULL
binding	NULL
specificity	NULL
for	NULL
AAGTGA-like	NULL
sequences	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
a	NULL
new	NULL
PRDI	NULL
binding	NULL
protein	NULL
is	NULL
relevant	NULL
to	NULL
IFN-8	NULL
transcription	NULL
,	NULL
since	NULL
experiments	NULL
from	NULL
other	NULL
systems	NULL
suggest	NULL
that	NULL
IRF-1	NULL
may	NULL
not	NULL
be	NULL
a	NULL
primary	NULL
transcriptional	NULL
regulatory	NULL
protein	NULL
but	NULL
rather	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
cofactor	NULL
in	NULL
transcriptional	NULL
activation	NULL
(	NULL
12	NULL
,	NULL
44	NULL
)	NULL
.	NULL

An	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
was	NULL
established	NULL
to	NULL
examine	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
purified	NULL
PRDI	NULL
and	NULL
PRDII	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
that	NULL
several	NULL
in	NULL
vivo	NULL
features	NULL
of	NULL
IFN-8	NULL
regulation	NULL
were	NULL
reproduced	NULL
in	NULL
vitro	NULL
using	NULL
specific	NULL
IFN-8	NULL
DNA	NULL
templates	NULL
.	NULL

1	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
of	NULL
IFN-8	NULL
templates	NULL
in	NULL
uninduced	NULL
and	NULL
IFN	NULL
treated	NULL
,	NULL
Sendai	NULL
virus	NULL
induced	NULL
HeLa	NULL
cells	NULL
resulted	NULL
in	NULL
correctly	NULL
initiated	NULL
transcription	NULL
from	NULL
the	NULL
authentic	NULL
mRNA	NULL
start	NULL
site	NULL
as	NULL
measured	NULL
by	NULL
S1	NULL
nuclease	NULL
mapping	NULL
;	NULL
furthermore	NULL
,	NULL
a	NULL
consistent	NULL
2-4-fold	NULL
stimulation	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
-281	NULL
and	NULL
-134	NULL
templates	NULL
was	NULL
observed	NULL
in	NULL
induced	NULL
extracts	NULL
compared	NULL
to	NULL
uninduced	NULL
extracts	NULL
.	NULL

2	NULL
.	NULL

Deletion	NULL
of	NULL
sequences	NULL
between	NULL
-281	NULL
and	NULL
-111	NULL
resulted	NULL
in	NULL
higher	NULL
basal	NULL
levels	NULL
of	NULL
correctly	NULL
initiated	NULL
transcripts	NULL
in	NULL
uninduced	NULL
extracts	NULL
,	NULL
demonstrating	NULL
that	NULL
sequences	NULL
upstream	NULL
of	NULL
-111	NULL
negatively	NULL
regulated	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
sequence	NULL
boundary	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
location	NULL
of	NULL
the	NULL
negative	NULL
regulatory	NULL
domain	NULL
NRDIL	NULL
(	NULL
5	NULL
,	NULL
8	NULL
)	NULL
.	NULL

3	NULL
.	NULL

Deletion	NULL
of	NULL
IFN-8	NULL
promoter	NULL
sequences	NULL
to	NULL
-67	NULL
resulted	NULL
in	NULL
a	NULL
basal	NULL
level	NULL
of	NULL
transcription	NULL
in	NULL
uninduced	NULL
extracts	NULL
that	NULL
was	NULL
not	NULL
increased	NULL
in	NULL
induced	NULL
extracts	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
inducibility	NULL
is	NULL
consistent	NULL
with	NULL
disruption	NULL
of	NULL
the	NULL
positive	NULL
regulatory	NULL
domain	NULL
PRD	NULL
!	NULL

(	NULL
3	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

4	NULL
.	NULL

The	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
were	NULL
responsible	NULL
for	NULL
both	NULL
basal	NULL
and	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
since	NULL
removal	NULL
of	NULL
these	NULL
sequences	NULL
completely	NULL
abrogated	NULL
transcription	NULL
in	NULL
uninduced	NULL
and	NULL
induced	NULL
extracts	NULL
.	NULL

5	NULL
.	NULL

Finally	NULL
,	NULL
addition	NULL
of	NULL
purified	NULL
PRD	NULL
and	NULL
PRDII	NULL
DNA	NULL
binding	NULL
proteins	NULL
to	NULL
the	NULL
transcription	NULL
reaction	NULL
produced	NULL
a	NULL
4-fold	NULL
increase	NULL
in	NULL
the	NULL
transcript	NULL
level	NULL
from	NULL
the	NULL
-134	NULL
template	NULL
,	NULL
demonstrating	NULL
that	NULL
these	NULL
proteins	NULL
played	NULL
a	NULL
role	NULL
in	NULL
positive	NULL
regulation	NULL
of	NULL
IFN-8	NULL
transcription	NULL
.	NULL

Stimulation	NULL
of	NULL
IFN-8	NULL
transcription	NULL
either	NULL
in	NULL
the	NULL
virus	NULL
induced	NULL
extracts	NULL
or	NULL
following	NULL
addition	NULL
of	NULL
purified	NULL
proteins	NULL
was	NULL
relatively	NULL
modest	NULL
throughout	NULL
these	NULL
studies	NULL
;	NULL
similar	NULL
increases	NULL
in	NULL
transcript	NULL
levels	NULL
have	NULL
also	NULL
been	NULL
observed	NULL
in	NULL
other	NULL
defined	NULL
in	NULL
vitro	NULL
transcription	NULL
assays	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
produce	NULL
a	NULL
3-fold	NULL
increase	NULL
in	NULL
transcription	NULL
from	NULL
the	NULL
HIV	NULL
enhancer	NULL
,	NULL
which	NULL
contains	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
;	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
IFN-8	NULL
promoter	NULL
contains	NULL
a	NULL
single	NULL
site	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
moderate	NULL
positive	NULL
effect	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

High	NULL
basal	NULL
levels	NULL
of	NULL
IFN-8	NULL
transcription	NULL
in	NULL
vitro	NULL
indicate	NULL
that	NULL
important	NULL
negative	NULL
regulatory	NULL
proteins	NULL
that	NULL
function	NULL
to	NULL
repress	NULL
transcription	NULL
in	NULL
vivo	NULL
may	NULL
be	NULL
lost	NULL
during	NULL
reconstitution	NULL
of	NULL
IFN-8	NULL
transcription	NULL
in	NULL
vitro	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
9	NULL
,	NULL
13	NULL
,	NULL
14	NULL
,	NULL
40	NULL
,	NULL
47	NULL
)	NULL
.	NULL

It	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
identify	NULL
and	NULL
purify	NULL
these	NULL
proteins	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
reflect	NULL
the	NULL
current	NULL
limitations	NULL
of	NULL
in	NULL
vitro	NULL
analysis	NULL
,	NULL
particularly	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
requirement	NULL
for	NULL
other	NULL
general	NULL
transcription	NULL
factors	NULL
or	NULL
non-DNA	NULL
binding	NULL
accessory	NULL
proteins	NULL
.	NULL

Nevertheless	NULL
,	NULL
these	NULL
experiments	NULL
have	NULL
demonstrated	NULL
that	NULL
is	NULL
is	NULL
possible	NULL
to	NULL
reproduce	NULL
some	NULL
of	NULL
the	NULL
regulatory	NULL
features	NULL
of	NULL
IFN-8	NULL
transcription	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
model	NULL
system	NULL
.	NULL

Future	NULL
experiments	NULL
will	NULL
be	NULL
aimed	NULL
at	NULL
defining	NULL
more	NULL
precisely	NULL
the	NULL
proteins	NULL
and	NULL
cofactors	NULL
mediating	NULL
basal	NULL
and	NULL
inducible	NULL
levels	NULL
of	NULL
interferon	NULL
transcription	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
and	NULL
Induction	NULL
Procedures	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
used	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
glutamine	NULL
and	NULL
antibiotics	NULL
.	NULL

T	NULL
lymphoid	NULL
Jurkat	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
complete	NULL
medium	NULL
containing	NULL
5	NULL
%	NULL
bovine	NULL
serum	NULL
,	NULL
and	NULL
HeLa	NULL
S3	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
25	NULL
mm	NULL
Hepes	NULL
(	NULL
pH	NULL
7.3	NULL
)	NULL
.	NULL

HeLa	NULL
S3	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
500	NULL
IU/	NULL
ml	NULL
of	NULL
recombinant	NULL
IFN-a	NULL
;	NULL
,	NULL
induced	NULL
with	NULL
cycloheximide	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
and	NULL
poly	NULL
{	NULL
[	NULL
I	NULL
:	NULL
C	NULL
]	NULL
(	NULL
25	NULL
ug/ml	NULL
)	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
subsequently	NULL
used	NULL
for	NULL
preparation	NULL
of	NULL
whole	NULL
cell	NULL
extract	NULL
(	NULL
9	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Jurkat	NULL
T-cells	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
density	NULL
of	NULL
10°	NULL
cells/ml	NULL
and	NULL
induced	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
25	NULL
ng/ml	NULL
for	NULL
6-8	NULL
h	NULL
before	NULL
preparation	NULL
of	NULL
whole	NULL
cell	NULL
extract	NULL
.	NULL

Whole	NULL
Cell	NULL
and	NULL
Nuclear	NULL
Extract	NULL
Preparations	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
after	NULL
the	NULL
induction	NULL
period	NULL
at	NULL
1200	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
cold	NULL
phosphate	NULL
buffered	NULL
saline	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
whole	NULL
cell	NULL
extract	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
Hepes	NULL
(	NULL
K*	NULL
)	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.2	NULL
mm	NULL
ethylene-glycol	NULL
bis	NULL
(	NULL
B-aminoethyl	NULL
ether	NULL
)	NULL
-N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
'	NULL
,	NULL
N	NULL
'	NULL
-tetraacetic	NULL
acid	NULL
,	NULL
0.5	NULL
mm	NULL
spermidine	NULL
,	NULL
0.15	NULL
mm	NULL
spermine	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
10	NULL
mm	NULL
sodium	NULL
molybdate	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
)	NULL
containing	NULL
0.5	NULL
mm	NULL
PMSF	NULL
and	NULL
1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
aprotinin	NULL
as	NULL
protease	NULL
inhibitors	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
2	NULL
m	NULL
KCI	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.5	NULL
m	NULL
KCI	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
gently	NULL
mixed	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Cell	NULL
debris	NULL
was	NULL
precipitated	NULL
by	NULL
centrifugation	NULL
at	NULL
35,000	NULL
rpm	NULL
in	NULL
a	NULL
Ti60	NULL
rotor	NULL
for	NULL
1	NULL
h	NULL
at	NULL
2°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
collected	NULL
and	NULL
diluted	NULL
to	NULL
0.1	NULL
m	NULL
KCl	NULL
with	NULL
WCE	NULL
buffer	NULL
(	NULL
9	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Protein	NULL
concentrations	NULL
for	NULL
the	NULL
different	NULL
uninduced	NULL
and	NULL
induced	NULL
extracts	NULL
ranged	NULL
between	NULL
1.5	NULL
and	NULL
2.0	NULL
mg/	NULL
ml	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
Shapiro	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
in	NULL
nuclear	NULL
dialysis	NULL
buffer	NULL
supplemented	NULL
with	NULL
protease	NULL
inhibitors	NULL
(	NULL
PMSF	NULL
at	NULL
0.5	NULL
mm	NULL
and	NULL
pepstatin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
aprotinin	NULL
at	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

Aliquots	NULL
were	NULL
quickly	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
.	NULL

The	NULL
band	NULL
retardation	NULL
assay	NULL
was	NULL
used	NULL
to	NULL
monitor	NULL
DNA	NULL
binding	NULL
activities	NULL
throughout	NULL
purification	NULL
as	NULL
follows	NULL
:	NULL
5	NULL
end	NULL
labeled	NULL
synthetic	NULL
oligonucleotides	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
crude	NULL
WCE	NULL
protein	NULL
(	NULL
0-15	NULL
ug	NULL
)	NULL
and	NULL
protein	NULL
from	NULL
different	NULL
column	NULL
fractions	NULL
(	NULL
as	NULL
described	NULL
in	NULL
individual	NULL
experiments	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.02-10	NULL
ug	NULL
of	NULL
poly	NULL
[	NULL
dl	NULL
:	NULL
dC	NULL
]	NULL
as	NULL
nonspecific	NULL
competitor	NULL
DNA	NULL
.	NULL

Unlabeled	NULL
specific	NULL
competitors	NULL
were	NULL
used	NULL
at	NULL
0-50	NULL
ng	NULL
as	NULL
described	NULL
.	NULL

Reactions	NULL
were	NULL
carried	NULL
out	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
in	NULL
WCE	NULL
buffer	NULL
containing	NULL
0.1	NULL
m	NULL
KCl	NULL
,	NULL
and	NULL
mixtures	NULL
were	NULL
then	NULL
loaded	NULL
on	NULL
a	NULL
5	NULL
%	NULL
native	NULL
Tris-glycine	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

After	NULL
running	NULL
at	NULL
100-150	NULL
V	NULL
for	NULL
3	NULL
h	NULL
,	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
film	NULL
at	NULL
-70°C	NULL
overnight	NULL
.	NULL

The	NULL
relative	NULL
intensities	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
measured	NULL
using	NULL
the	NULL
LKB	NULL
Utroscan	NULL
XL	NULL
scanning	NULL
laser	NULL
densitometer	NULL
;	NULL
the	NULL
value	NULL
obtained	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
crude	NULL
extract	NULL
was	NULL
taken	NULL
as	NULL
1	NULL
unit	NULL
of	NULL
activity	NULL
.	NULL

332	NULL
IFN-8	NULL
Protein-DNA	NULL
Interactions	NULL
Protein	NULL
Purification	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
,	NULL
prepared	NULL
from	NULL
20	NULL
ml	NULL
of	NULL
IFN/cycloheximide/poly	NULL
[	NULL
rl	NULL
:	NULL
rC	NULL
]	NULL
induced	NULL
HeLa	NULL
S3	NULL
packed	NULL
cell	NULL
pellets	NULL
and	NULL
from	NULL
58	NULL
ml	NULL
of	NULL
PMA-induced	NULL
Jurkat	NULL
packed	NULL
cell	NULL
pellets	NULL
,	NULL
were	NULL
applied	NULL
to	NULL
a	NULL
DEAE-Sephacel	NULL
column	NULL
(	NULL
bed	NULL
volumes	NULL
,	NULL
100	NULL
and	NULL
200	NULL
ml	NULL
)	NULL
equilibrated	NULL
with	NULL
WCE	NULL
buffer	NULL
containing	NULL
0.5	NULL
m	NULL
KCl	NULL
.	NULL

Flow-through	NULL
fractions	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
precipitated	NULL
with	NULL
solid	NULL
ammonium	NULL
sulfate	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
70	NULL
%	NULL
.	NULL

After	NULL
resuspension	NULL
in	NULL
buffer	NULL
Z	NULL
(	NULL
25	NULL
mm	NULL
Hepes	NULL
(	NULL
K*	NULL
)	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mm	NULL
PMSF	NULL
,	NULL
and	NULL
2	NULL
ug/ml	NULL
each	NULL
of	NULL
leupeptin	NULL
,	NULL
aprotinin	NULL
,	NULL
and	NULL
pepstatin	NULL
)	NULL
containing	NULL
0.1	NULL
m	NULL
KCl	NULL
,	NULL
the	NULL
extracts	NULL
were	NULL
fractionated	NULL
by	NULL
gel	NULL
filtration	NULL
on	NULL
Sephacryl	NULL
300	NULL
HR	NULL
resin	NULL
columns	NULL
(	NULL
bed	NULL
volumes	NULL
,	NULL
120	NULL
and	NULL
500	NULL
mi	NULL
)	NULL
,	NULL
equilibrated	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
(	NULL
the	NULL
500	NULL
ml	NULL
bed	NULL
volume	NULL
column	NULL
was	NULL
run	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
glycerol	NULL
to	NULL
allow	NULL
the	NULL
use	NULL
of	NULL
a	NULL
higher	NULL
flow	NULL
rate	NULL
)	NULL
.	NULL

Active	NULL
fractions	NULL
were	NULL
pooled	NULL
(	NULL
25	NULL
ml	NULL
for	NULL
HeLa	NULL
S3	NULL
cell	NULL
extracts	NULL
and	NULL
80	NULL
ml	NULL
for	NULL
Jurkat	NULL
cell	NULL
extracts	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
nonspecific	NULL
DNA	NULL
,	NULL
herring	NULL
sperm	NULL
DNA	NULL
,	NULL
and	NULL
poly	NULL
[	NULL
dl	NULL
:	NULL
dC	NULL
]	NULL
(	NULL
200	NULL
and	NULL
300	NULL
ug	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
HeLa	NULL
S3	NULL
extracts	NULL
and	NULL
500	NULL
ug	NULL
and	NULL
1.5	NULL
mg	NULL
for	NULL
Jurkat	NULL
extracts	NULL
)	NULL
.	NULL

After	NULL
10	NULL
min	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
fractions	NULL
were	NULL
applied	NULL
to	NULL
specific	NULL
oligonucleotide	NULL
DNA	NULL
affinity	NULL
columns	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Kadonaga	NULL
and	NULL
Tjian	NULL
(	NULL
48	NULL
)	NULL
,	NULL
using	NULL
multimerized	NULL
P2	NULL
sequences	NULL
or	NULL
multimers	NULL
of	NULL
the	NULL
tetrahexamer	NULL
(	NULL
AAGTGA	NULL
)	NULL
,	NULL
sequence	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
a	NULL
stepwise	NULL
KCl	NULL
gradient	NULL
(	NULL
0.1-1	NULL
m	NULL
)	NULL
in	NULL
buffer	NULL
Z.	NULL
Fractions	NULL
with	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
mobility	NULL
shift	NULL
assay	NULL
were	NULL
pooled	NULL
and	NULL
purified	NULL
by	NULL
two	NULL
additional	NULL
cycles	NULL
of	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
a	NULL
Bio-Rad	NULL
microas-say	NULL
,	NULL
during	NULL
the	NULL
purification	NULL
steps	NULL
.	NULL

Purified	NULL
fractions	NULL
were	NULL
analyzed	NULL
on	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
and	NULL
silver	NULL
stained	NULL
using	NULL
a	NULL
Bio-Rad	NULL
silver	NULL
staining	NULL
kit	NULL
.	NULL

UV	NULL
Cross-Linking	NULL
.	NULL

A	NULL
BrdUrd	NULL
substituted	NULL
P2	NULL
oligonucleotide	NULL
(	NULL
43	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
protein	NULL
from	NULL
the	NULL
third	NULL
cycle	NULL
of	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
in	NULL
a	NULL
standard	NULL
mobility	NULL
shift	NULL
reaction	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
directly	NULL
exposed	NULL
to	NULL
UV	NULL
shadowing	NULL
using	NULL
a	NULL
Spectroline	NULL
transilluminator	NULL
(	NULL
302	NULL
nm	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Reactions	NULL
were	NULL
diluted	NULL
in	NULL
2	NULL
%	NULL
sample	NULL
buffer	NULL
and	NULL
loaded	NULL
directly	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

Construction	NULL
of	NULL
Plasmids	NULL
Containing	NULL
Mutant	NULL
Genes	NULL
.	NULL

5	NULL
deletion	NULL
mutants	NULL
were	NULL
created	NULL
using	NULL
the	NULL
Erase-a-base	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
starting	NULL
with	NULL
the	NULL
plasmid	NULL
pT	NULL
;	NULL
T	NULL
;	NULL
18	NULL
into	NULL
which	NULL
the	NULL
1.8-kilobase	NULL
EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
IFN-8	NULL
gene	NULL
had	NULL
been	NULL
inserted	NULL
.	NULL

Essentially	NULL
,	NULL
this	NULL
technique	NULL
consists	NULL
of	NULL
linearizing	NULL
the	NULL
plasmid	NULL
with	NULL
BamHI	NULL
to	NULL
generate	NULL
a	NULL
5	NULL
overhang	NULL
and	NULL
Pstl	NULL
to	NULL
generate	NULL
a	NULL
3	NULL
'	NULL
overhang	NULL
,	NULL
followed	NULL
by	NULL
digestion	NULL
with	NULL
exonuclease	NULL
III	NULL
and	NULL
S1	NULL
nuclease	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
plasmid	NULL
DNA	NULL
was	NULL
filled	NULL
in	NULL
with	NULL
Klenow	NULL
and	NULL
religated	NULL
.	NULL

Following	NULL
preliminary	NULL
screening	NULL
of	NULL
the	NULL
size	NULL
of	NULL
the	NULL
deletion	NULL
in	NULL
individual	NULL
clones	NULL
,	NULL
the	NULL
end	NULL
point	NULL
of	NULL
each	NULL
deletion	NULL
matant	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription	NULL
Assay	NULL
.	NULL

Nuclear	NULL
extract	NULL
from	NULL
uninduced	NULL
or	NULL
induced	NULL
HeLa	NULL
S3	NULL
cells	NULL
was	NULL
prepared	NULL
and	NULL
used	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
reconstituted	NULL
transcription	NULL
assay	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
35	NULL
)	NULL
,	NULL
with	NULL
the	NULL
following	NULL
modifica-tions	NULL
:	NULL
transcription	NULL
reactions	NULL
(	NULL
40-50	NULL
1	NULL
)	NULL
containing	NULL
1.5-2	NULL
ug/ul	NULL
of	NULL
nuclear	NULL
extract	NULL
were	NULL
preincubated	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
enriched	NULL
fractions	NULL
or	NULL
TH	NULL
enriched	NULL
fractions	NULL
(	NULL
0-20	NULL
ng	NULL
)	NULL
were	NULL
added	NULL
,	NULL
and	NULL
reactions	NULL
were	NULL
started	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
500	NULL
ng	NULL
of	NULL
IFN	NULL
B	NULL
DNA	NULL
template	NULL
,	NULL
250	NULL
ng	NULL
of	NULL
rabbit	NULL
B-globin	NULL
DNA	NULL
,	NULL
and	NULL
four	NULL
ribonucleoside	NULL
triphosphates	NULL
(	NULL
100	NULL
um	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

After	NULL
1	NULL
h	NULL
at	NULL
30°C	NULL
,	NULL
RNA	NULL
was	NULL
harvested	NULL
by	NULL
a	NULL
small	NULL
scale	NULL
guanidinium	NULL
isothiocyanate	NULL
procedure	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Quantifica-tion	NULL
of	NULL
RNA	NULL
transcripts	NULL
was	NULL
performed	NULL
by	NULL
S1	NULL
mapping	NULL
(	NULL
37	NULL
)	NULL
using	NULL
the	NULL
5	NULL
end	NULL
labeled	NULL
922-bp	NULL
Bg/ll-EcoRl	NULL
IFN-8	NULL
probe	NULL
.	NULL

Rabbit	NULL
-globin	NULL
RNA	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
575-bp	NULL
BamHI-Pstl	NULL
RBG	NULL
probe	NULL
.	NULL

Autoradiographs	NULL
of	NULL
the	NULL
exposed	NULL
film	NULL
were	NULL
scanned	NULL
on	NULL
the	NULL
LKB	NULL
Ultroscan	NULL
XL	NULL
laser	NULL
densitometer	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription	NULL
and	NULL
Translation	NULL
of	NULL
IRF-1	NULL
,	NULL
.	NULL

The	NULL
IRF-1	NULL
complementary	NULL
DNA	NULL
,	NULL
obtained	NULL
from	NULL
Dr.	NULL
T.	NULL
Fujita	NULL
,	NULL
was	NULL
excised	NULL
from	NULL
pHIRF1-31	NULL
plasmid	NULL
and	NULL
subcloned	NULL
in	NULL
pBluescript	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

One	NULL
ug	NULL
of	NULL
the	NULL
pBluescript/IRF-1	NULL
construct	NULL
was	NULL
digested	NULL
with	NULL
Dral	NULL
and	NULL
used	NULL
in	NULL
a	NULL
25-ul	NULL
transcription	NULL
reaction	NULL
containing	NULL
the	NULL
T7	NULL
polymerase	NULL
,	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

After	NULL
extraction	NULL
,	NULL
RNA	NULL
was	NULL
redissolved	NULL
in	NULL
25	NULL
al	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
2.5	NULL
ul	NULL
were	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
translation	NULL
using	NULL
a	NULL
wheat	NULL
germ	NULL
extract	NULL
in	NULL
a	NULL
25-4ul	NULL
reaction	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

/n	NULL
vitro	NULL
translated	NULL
IRF-1	NULL
and	NULL
the	NULL
TH	NULL
fraction	NULL
(	NULL
500	NULL
ng	NULL
)	NULL
eluted	NULL
from	NULL
the	NULL
first	NULL
cycle	NULL
of	NULL
TH	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
onto	NULL
nitrocellu-lose	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
polyclonal	NULL
antibody	NULL
directed	NULL
against	NULL
ISGF-2/IRF-1	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
R.	NULL
Pine	NULL
)	NULL
and	NULL
then	NULL
developed	NULL
using	NULL
a	NULL
sensitive	NULL
chemilumi-nescence	NULL
Western	NULL
blotting	NULL
detection	NULL
system	NULL
(	NULL
Amer-sham	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
after	NULL
incubation	NULL
overnight	NULL
with	NULL
the	NULL
primary	NULL
antibody	NULL
,	NULL
the	NULL
nitrocellulose	NULL
was	NULL
rinsed	NULL
with	NULL
phosphate	NULL
buffered	NULL
saline	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
a	NULL
horseradish	NULL
peroxidase-coupled	NULL
secondary	NULL
goat	NULL
anti-rab-bit	NULL
antibody	NULL
;	NULL
the	NULL
reaction	NULL
was	NULL
developed	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
Richard	NULL
Pine	NULL
for	NULL
antibody	NULL
to	NULL
IRF-1/ISGF-2	NULL
and	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
and	NULL
Dr.	NULL
T.	NULL
Fujita	NULL
for	NULL
the	NULL
IRF-1	NULL
plasmid	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Sandy	NULL
Fraiberg	NULL
and	NULL
Rhona	NULL
Rosenzweig	NULL
for	NULL
typing	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

DeMaeyer	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
DeMaeyer-Guinard	NULL
,	NULL
J.	NULL
Interferon	NULL
and	NULL
Other	NULL
Regulatory	NULL
Cytokines	NULL
.	NULL

New	NULL
York	NULL
:	NULL
John	NULL
Wiley	NULL
and	NULL
Sons	NULL
,	NULL
1988	NULL
.	NULL

2	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
Regulation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
6	NULL
:	NULL
439-464	NULL
,	NULL
1988	NULL
.	NULL

3	NULL
.	NULL

Fan	NULL
,	NULL
C-M.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Two	NULL
different	NULL
virus-inducible	NULL
elements	NULL
are	NULL
required	NULL
for	NULL
human	NULL
B-interferon	NULL
gene	NULL
regulation	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
8	NULL
:	NULL
101-110	NULL
,	NULL
1989	NULL
.	NULL

4	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Hotta	NULL
,	NULL
H.	NULL
,	NULL
Yamanishi	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Interferon-8	NULL
gene	NULL
regulation	NULL
:	NULL
tandemly	NULL
repeated	NULL
sequences	NULL
of	NULL
a	NULL
synthetic	NULL
6	NULL
bp	NULL
oligomer	NULL
function	NULL
as	NULL
a	NULL
virus-inducible	NULL
enhancer	NULL
.	NULL

Cell	NULL
,	NULL
49	NULL
;	NULL
357-367	NULL
,	NULL
1987	NULL
.	NULL

5	NULL
.	NULL

Goodbourn	NULL
,	NULL
S.	NULL
,	NULL
Burstein	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
The	NULL
human	NULL
B-interferon	NULL
gene	NULL
enhancer	NULL
is	NULL
under	NULL
negative	NULL
control	NULL
.	NULL

Cell	NULL
,	NULL
45	NULL
:	NULL
601-610	NULL
,	NULL
1986	NULL
.	NULL

6	NULL
.	NULL

Goodbourn	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Overlapping	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
domains	NULL
of	NULL
the	NULL
human	NULL
B-interferon	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
1447-1451	NULL
,	NULL
1988	NULL
.	NULL

7	NULL
.	NULL

Leblanc	NULL
,	NULL
|-F.	NULL
,	NULL
Cohen	NULL
,	NULL
L.	NULL
,	NULL
Rodrigues	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hiscott	NULL
,	NULL
J.	NULL
Synergism	NULL
between	NULL
distinct	NULL
enhanson	NULL
domains	NULL
in	NULL
viral	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
8	NULL
interferon	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
3987-3993	NULL
,	NULL
1990	NULL
.	NULL

8	NULL
.	NULL

Zinn	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Detection	NULL
of	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
human	NULL
B-interferon	NULL
regulatory	NULL
region	NULL
in	NULL
vivo	NULL
by	NULL
DNase	NULL
|	NULL
footprinting	NULL
.	NULL

Cell	NULL
,	NULL
45	NULL
:	NULL
611-618	NULL
,	NULL
1986	NULL
.	NULL

9	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Sakakibara	NULL
,	NULL
J.	NULL
,	NULL
Sudo	NULL
,	NULL
Y.	NULL
,	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Kimura	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Evidence	NULL
for	NULL
a	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
IRF-1	NULL
,	NULL
mediating	NULL
induction	NULL
and	NULL
silencing	NULL
properties	NULL
to	NULL
human	NULL
IFN-8	NULL
gene	NULL
regulatory	NULL
elements	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
7	NULL
:	NULL
3397-3405	NULL
,	NULL
1988	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
10	NULL
.	NULL

Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Kimura	NULL
,	NULL
Y.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Sudo	NULL
,	NULL
Y.	NULL
,	NULL
Miyata	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Regulated	NULL
expression	NULL
of	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
nuclear	NULL
factor	NULL
,	NULL
IRF-1	NULL
,	NULL
that	NULL
specifically	NULL
binds	NULL
to	NULL
IFN-8	NULL
gene	NULL
regulatory	NULL
elements	NULL
.	NULL

Cell	NULL
,	NULL
54	NULL
:	NULL
903-913	NULL
,	NULL
1988	NULL
.	NULL

11	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Kimura	NULL
,	NULL
Y.	NULL
,	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Barsouniam	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Induction	NULL
of	NULL
endogenous	NULL
IFN-a	NULL
and	NULL
IFN-	NULL
genes	NULL
by	NULL
a	NULL
regulatory	NULL
transcription	NULL
factor	NULL
,	NULL
IRF-1	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
337	NULL
:	NULL
270-272	NULL
,	NULL
1989	NULL
.	NULL

12	NULL
.	NULL

Pine	NULL
,	NULL
R.	NULL
,	NULL
Decker	NULL
,	NULL
T.	NULL
,	NULL
Kessler	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
Purification	NULL
and	NULL
cloning	NULL
of	NULL
interferon-stimulated	NULL
gene	NULL
factor	NULL
2	NULL
(	NULL
ISGF2	NULL
)	NULL
:	NULL
ISGF2	NULL
{	NULL
IRF-1	NULL
)	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
promoters	NULL
of	NULL
both	NULL
beta	NULL
interferon	NULL
and	NULL
interferon-stimulated	NULL
genes	NULL
but	NULL
is	NULL
not	NULL
a	NULL
primary	NULL
transcriptional	NULL
activator	NULL
of	NULL
either	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
6	NULL
:	NULL
2448-2457	NULL
,	NULL
1990	NULL
.	NULL

13	NULL
.	NULL

Harada	NULL
,	NULL
H.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Kimura	NULL
,	NULL
Y.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Furia	NULL
,	NULL
A.	NULL
,	NULL
Miyata	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Structurally	NULL
similar	NULL
but	NULL
functionally	NULL
distinct	NULL
factors	NULL
,	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
,	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
regulatory	NULL
elements	NULL
of	NULL
IFN	NULL
and	NULL
IFN-inducible	NULL
genes	NULL
.	NULL

Cell	NULL
,	NULL
58	NULL
:	NULL
729-739	NULL
,	NULL
1989	NULL
.	NULL

14	NULL
.	NULL

Whittemore	NULL
,	NULL
L-A	NULL
.	NULL

,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Postinduction	NULL
repression	NULL
of	NULL
the	NULL
B-interferon	NULL
gene	NULL
is	NULL
mediated	NULL
through	NULL
two	NULL
positive	NULL
regulatory	NULL
domains	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
7799-7803	NULL
,	NULL
1990	NULL
.	NULL

15	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Inducibility	NULL
of	NULL
«	NULL
immunoglobulin	NULL
enhancer-binding	NULL
protein	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
a	NULL
posttranslational	NULL
mechanism	NULL
.	NULL

Cell	NULL
,	NULL
47	NULL
:	NULL
921-928	NULL
,	NULL
1986	NULL
.	NULL

16	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
,	NULL
58	NULL
:	NULL
227-229	NULL
,	NULL
1989	NULL
.	NULL

17	NULL
.	NULL

Fan	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
A	NULL
DNA-binding	NULL
protein	NULL
containing	NULL
two	NULL
widely	NULL
separated	NULL
zinc	NULL
finger	NULL
motifs	NULL
that	NULL
recognize	NULL
the	NULL
same	NULL
DNA	NULL
sequence	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
:	NULL
29-42	NULL
,	NULL
1990	NULL
.	NULL

18	NULL
.	NULL

Clark	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Hay	NULL
,	NULL
R.	NULL
T.	NULL
Sequence	NULL
requirement	NULL
for	NULL
specific	NULL
interaction	NULL
of	NULL
an	NULL
enhancer	NULL
binding	NULL
protein	NULL
(	NULL
EBP1	NULL
)	NULL
with	NULL
DNA	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
:	NULL
499-516	NULL
,	NULL
1989	NULL
.	NULL

19	NULL
.	NULL

Visvanathan	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
and	NULL
Goodbourn	NULL
,	NULL
S.	NULL
Double-stranded	NULL
RNA	NULL
activates	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
an	NULL
inducible	NULL
element	NULL
in	NULL
the	NULL
human	NULL
B-interferon	NULL
promoter	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
8	NULL
:	NULL
1129-1138	NULL
,	NULL
1989	NULL
.	NULL

20	NULL
.	NULL

Hiscott	NULL
,	NULL
J.	NULL
,	NULL
Alper	NULL
,	NULL
D.	NULL
,	NULL
Cohen	NULL
,	NULL
L.	NULL
,	NULL
Leblanc	NULL
,	NULL
J-F.	NULL
,	NULL
Sportza	NULL
,	NULL
L.	NULL
,	NULL
Wong	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Xanthoudakis	NULL
,	NULL
S.	NULL
Induction	NULL
of	NULL
human	NULL
interferon	NULL
gene	NULL
expression	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
nuclear	NULL
factor	NULL
that	NULL
interacts	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
63	NULL
:	NULL
2557-2566	NULL
,	NULL
1989	NULL
.	NULL

21	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Fan	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
The	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
B-interferon	NULL
gene	NULL
regulation	NULL
reveals	NULL
its	NULL
role	NULL
as	NULL
widely	NULL
inducible	NULL
mediator	NULL
of	NULL
signal	NULL
transduction	NULL
.	NULL

Cell	NULL
,	NULL
57	NULL
:	NULL
287-294	NULL
,	NULL
1989	NULL
.	NULL

22	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Kimura	NULL
,	NULL
Y.	NULL
,	NULL
Hammer	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Involvement	NULL
of	NULL
a	NULL
cis-element	NULL
that	NULL
binds	NULL
an	NULL
H2TF-1/NF-	NULL
«	NULL
B	NULL
like	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
virus-induced	NULL
interferon-	NULL
gene	NULL
expression	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
:	NULL
3335-3346	NULL
,	NULL
1989	NULL
.	NULL

23	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
C.	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
:	NULL
2336-2340	NULL
,	NULL
1989	NULL
.	NULL

24	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J.	NULL
HTLV-1	NULL
trans-activator	NULL
induces	NULL
interleu-kin-2	NULL
receptor	NULL
expression	NULL
through	NULL
a	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
333	NULL
:	NULL
776-778	NULL
,	NULL
1988	NULL
.	NULL

25	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
IB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
242	NULL
:	NULL
540-546	NULL
,	NULL
1988	NULL
.	NULL

26	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
A	NULL
65	NULL
kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
i	NULL
«	NULL
B	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
:	NULL
1689-1698	NULL
,	NULL
1989	NULL
.	NULL

27	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

The	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
receptor	NULL
for	NULL
IkB	NULL
and	NULL
a	NULL
modulator	NULL
of	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
:	NULL
1975-1984	NULL
,	NULL
1990	NULL
.	NULL

28	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Lion	NULL
,	NULL
H-C.	NULL
,	NULL
Tempest	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
DNA	NULL
binding	NULL
and	NULL
I	NULL
«	NULL
B	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
rel-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
,	NULL
64	NULL
:	NULL
961-969	NULL
,	NULL
1991	NULL
.	NULL

29	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
10028-10032	NULL
,	NULL
1990	NULL
.	NULL

30	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kouriisky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
re/	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
:	NULL
1007-1018	NULL
,	NULL
1990	NULL
.	NULL

31	NULL
.	NULL

Yano	NULL
,	NULL
O.	NULL
,	NULL
Kanellopoulos	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
Israél	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kouritski	NULL
,	NULL
P.	NULL
Purification	NULL
of	NULL
KBF1	NULL
,	NULL
a	NULL
common	NULL
factor	NULL
binding	NULL
to	NULL
both	NULL
H-2	NULL
and	NULL
82-microglobulin	NULL
enhancers	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
6	NULL
:	NULL
3317-3324	NULL
,	NULL
1987	NULL
.	NULL

32	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Temps	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
homol-ogy	NULL
to	NULL
rel	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
:	NULL
1019-1029	NULL
,	NULL
1990	NULL
.	NULL

33	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Sista	NULL
,	NULL
P.	NULL
,	NULL
Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Hannink	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
The	NULL
v-re	NULL
!	NULL

oncogene	NULL
encodes	NULL
a	NULL
«	NULL
B	NULL
enhancer	NULL
binding	NULL
protein	NULL
than	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
.	NULL

Cell	NULL
,	NULL
63	NULL
:	NULL
803-814	NULL
,	NULL
1990	NULL
.	NULL

34	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
KBF1	NULL
,	NULL
dorsal	NULL
and	NULL
related	NULL
matters	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
:	NULL
841-843	NULL
,	NULL
1990	NULL
.	NULL

35	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
Cohen	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Hiscott	NULL
,	NULL
J	NULL
.	NULL

Multiple	NULL
protein-DNA	NULL
interactions	NULL
within	NULL
the	NULL
human	NULL
interferon	NULL
8	NULL
regulatory	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
,	NULL
Chem	NULL
.	NULL

,	NULL
264	NULL
:	NULL
1139-1145	NULL
,	NULL
1989	NULL
.	NULL

36	NULL
.	NULL

Shapiro	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
,	NULL
Wahli	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
and	NULL
Keller	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

A	NULL
high	NULL
efficiency	NULL
Hela	NULL
cell	NULL
nuclear	NULL
transcription	NULL
extract	NULL
.	NULL

DNA	NULL
,	NULL
7	NULL
:	NULL
47-56	NULL
,	NULL
1988	NULL
.	NULL

37	NULL
.	NULL

Weaver	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Weissmann	NULL
,	NULL
C.	NULL
Mapping	NULL
of	NULL
RNA	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
Berk-Sharp	NULL
procedure	NULL
:	NULL
the	NULL
5	NULL
``	NULL
termini	NULL
of	NULL
mRNA	NULL
precursor	NULL
and	NULL
mature	NULL
108	NULL
mRNA	NULL
have	NULL
identical	NULL
map	NULL
coordinates	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
7	NULL
:	NULL
1175-1193	NULL
,	NULL
1979	NULL
.	NULL

38	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Ohno	NULL
,	NULL
S.	NULL
,	NULL
Yasumitsu	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Delimitation	NULL
and	NULL
properties	NULL
of	NULL
DNA	NULL
sequences	NULL
required	NULL
for	NULL
the	NULL
regulated	NULL
expression	NULL
of	NULL
human	NULL
interferon-8	NULL
gene	NULL
.	NULL

Cell	NULL
,	NULL
41	NULL
:	NULL
489-496	NULL
,	NULL
1985	NULL
.	NULL

39	NULL
.	NULL

MacDonald	NULL
,	NULL
N.	NULL
,	NULL
Kuhl	NULL
,	NULL
D.	NULL
,	NULL
Maguire	NULL
,	NULL
D.	NULL
,	NULL
Naf	NULL
,	NULL
D.	NULL
,	NULL
Gallant	NULL
,	NULL
P.	NULL
,	NULL
Goswamy	NULL
,	NULL
A.	NULL
,	NULL
Hug	NULL
,	NULL
H.	NULL
,	NULL
Buéler	NULL
,	NULL
H.	NULL
,	NULL
Chaturvedi	NULL
,	NULL
M.	NULL
,	NULL
de	NULL
la	NULL
Fuente	NULL
,	NULL
J.	NULL
,	NULL
Ruffner	NULL
,	NULL
H.	NULL
,	NULL
Meyer	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Weissmann	NULL
,	NULL
C.	NULL
Different	NULL
pathways	NULL
mediate	NULL
virus	NULL
inducibility	NULL
of	NULL
the	NULL
human	NULL
IFN-a1	NULL
and	NULL
IFN-	NULL
genes	NULL
.	NULL

Cell	NULL
,	NULL
60	NULL
:	NULL
767-779	NULL
,	NULL
1990	NULL
.	NULL

40	NULL
.	NULL

Keller	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Identification	NULL
of	NULL
an	NULL
inducible	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
3309-3313	NULL
,	NULL
1988	NULL
.	NULL

41	NULL
.	NULL

Goodbourn	NULL
,	NULL
S.	NULL
,	NULL
Zinn	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Human	NULL
A-interferon	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
inducible	NULL
enhancer	NULL
element	NULL
.	NULL

Cell	NULL
,	NULL
41	NULL
:	NULL
509-520	NULL
,	NULL
1985	NULL
.	NULL

42	NULL
.	NULL

Lacoste	NULL
,	NULL
J.	NULL
,	NULL
D'Addario	NULL
,	NULL
M.	NULL
,	NULL
Roulston	NULL
,	NULL
A.	NULL
,	NULL
Wainberg	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hiscott	NULL
,	NULL
J	NULL
.	NULL

Cell	NULL
specific	NULL
differences	NULL
in	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
regulatory	NULL
elements	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
and	NULL
beta	NULL
interferon	NULL
promoters	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
:	NULL
4726-4734	NULL
,	NULL
1990	NULL
.	NULL

43	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Hiscott	NULL
,	NULL
J.	NULL
UV	NULL
cross-linking	NULL
of	NULL
distinct	NULL
proteins	NULL
to	NULL
the	NULL
PRDII	NULL
domain	NULL
of	NULL
the	NULL
interferon	NULL
8	NULL
promoter	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
167	NULL
;	NULL
1086-1093	NULL
,	NULL
1990	NULL
.	NULL

44	NULL
.	NULL

Israél	NULL
,	NULL
A.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Hatat	NULL
,	NULL
D.	NULL
,	NULL
Piette	NULL
,	NULL
J.	NULL
,	NULL
Kieran	NULL
,	NULL
M.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Wallach	NULL
,	NULL
D.	NULL
,	NULL
Fellous	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kourilsky	NULL
,	NULL
P.	NULL
TNF	NULL
stimulates	NULL
expression	NULL
of	NULL
mouse	NULL
MHC	NULL
class	NULL
I	NULL
genes	NULL
by	NULL
inducing	NULL
an	NULL
NF-xB-like	NULL
enhancer	NULL
binding	NULL
activity	NULL
which	NULL
displaces	NULL
constitutive	NULL
factors	NULL
,	NULL
EMBO	NULL
J.	NULL
,	NULL
8	NULL
:	NULL
3793-3800	NULL
,	NULL
1989	NULL
.	NULL

45	NULL
.	NULL

Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
Identification	NULL
and	NULL
purification	NULL
of	NULL
a	NULL
human	NULL
immunoglobulin-enhancer-binding	NULL
protein	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
that	NULL
activates	NULL
transcription	NULL
from	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
4700-4704	NULL
,	NULL
1988	NULL
.	NULL

46	NULL
.	NULL

England	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Heberlein	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
Purified	NULL
Drosophila	NULL
transcription	NULL
factor	NULL
,	NULL
Adh	NULL
distal	NULL
factor-1	NULL
{	NULL
(	NULL
Adf-1	NULL
}	NULL
binds	NULL
to	NULL
sites	NULL
in	NULL
several	NULL
Drosophila	NULL
promoters	NULL
and	NULL
activates	NULL
transcription	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
:	NULL
5086-5094	NULL
,	NULL
1990	NULL
.	NULL

47	NULL
.	NULL

Haggarty	NULL
,	NULL
A.	NULL
,	NULL
Ponton	NULL
,	NULL
A.	NULL
,	NULL
Paterno	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Daigneault	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Skup	NULL
,	NULL
D.	NULL
An	NULL
embryonic	NULL
DNA-binding	NULL
protein	NULL
specific	NULL
for	NULL
a	NULL
region	NULL
of	NULL
the	NULL
IFN-8	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
16	NULL
:	NULL
10575-10592	NULL
,	NULL
1988	NULL
.	NULL

48	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
Affinity	NULL
purification	NULL
of	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
83	NULL
:	NULL
5889-5893	NULL
,	NULL
1986	NULL
.	NULL

49	NULL
.	NULL

Chomczynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
162	NULL
:	NULL
156-159	NULL
,	NULL
1987	NULL
.	NULL

333	NULL

